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ABSTRACT
MicroRNAs (miRNAs) are short ribonucleic acids that ultimately affect the
production of proteins. Although miRNAs are involved in nearly every biological process
examined to date, little is known of the identity or function of miRNA in porcine
reproductive tissues or their potential involvement in reproductive processes in pigs or
other species. The objective of this dissertation research was to determine the presence of
miRNAs in porcine gametes and both in vivo- and in vitro- produced pre-implantation
embryos and to identify differences in miRNA expression between normal and aberrant
samples. Using a heterologous RT-PCR approach, we demonstrated the presence of a
total of 92 miRNAs in porcine oocytes, spermatozoa, and/ or embryos at the 4-cell, 8cell, 16-cell, and blastocyst stages, with hundreds more predicted by miRNA microarray.
Subsequent qRT-PCR analysis showed differential expression of five miRNAs, let-7a, 7d, -7e, miR-15b, and -22, between normal sperm and morphologically abnormal sperm
or sperm samples exhibiting low motility. Messenger RNA targets of the differentially
expressed miRNAs encode proteins important for spermatogenesis, sperm structure, and/
or sperm cell metabolism. Differential expression was also shown among embryos at
various stages in development, demonstrating a temporal expression pattern of specific
miRNAs in pre-implantation embryo growth. More interestingly, miR-24 was
differentially expressed between in vivo- and in vitro- produced embryos at the 8-cell and
blastocyst stages, supporting the need to characterize aberrant miRNA expression
associated with the abnormal embryonic development correlated with assisted
reproductive technologies. All of the miRNAs examined demonstrated high sequence
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similarity to the corresponding human miRNA sequences, indicative of high conservation
among species. Understanding miRNA expression in reproductive processes is critical to
comprehending the mechanistic roles miRNAs play in the regulation of all physiological
processes.
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CHAPTER ONE
LITERATURE REVIEW

Overview
MicroRNAs (miRNAs) are short ribonucleic acids that ultimately affect the
production of proteins by regulating translation of mRNA. Although miRNAs are
involved in nearly every biological process examined to date, little is known of the
identity or function of miRNA in porcine reproductive tissues or their potential
involvement in reproductive processes. MiRNAs have been implicated in diverse
physiological processes such as insulin secretion (Poy et al., 2004), adipocyte
differentiation (Kajimoto et al., 2006; Pratt, 2010), alcohol tolerance (Pietrzykowski et
al., 2008), and carcinogenesis (as reviewed by Cuellar et al., 2005). They have also been
shown to play roles in reproductive processes such as oocyte maturation (Tesfaye et al.,
2009), spermatogenesis (Maatouk et al., 2008), embryonic development (Houbaviy et al.,
2003) and placenta formation (Cui et al., 2009).
Assisted reproduction techniques (ART), such as in vitro fertilization (IVF),
intracytoplasmic sperm injection (ICSI), and somatic cell nuclear transfer (SCNT)
frequently lead to aberrant gene expression and are implicated for the failure of the
resulting embryos to establish and/or maintain pregnancy following transfer (Khosla et
al., 2001; Vajta, 2007; Young et al., 1998). The underlying cause for decreased survival
of in vitro produced embryos is unknown but it is highly possible that the expression of
miRNAs is altered during procedures such ICSI, SCNT, and in vitro culture affecting the
translation of specific messenger RNA and negatively impacting embryonic
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development. The goal of this research was to identify miRNAs in porcine sperm samples
of varying qualities and in both in vivo and in vitro produced porcine embryos at varying
stages in pre-implantation development. Understanding miRNA expression is critical to
comprehending the mechanistic roles miRNAs play in the regulation of reproductive
processes.
History
Lee and her colleagues at Harvard University (1993) discovered the first miRNA, lin4, while studying larval development in the nematode C. elegans. They knew that the
ablation of lin-4 function caused aberrant stage progression and absence of adult
structures (Chalfie et al., 1981) and that lin-4 was a negative regulator of lin-14, which
encodes the protein LIN-14. Interestingly, as levels of lin-4 increased, protein levels of
LIN-14 decreased, but mRNA transcript levels of lin-14 remained constant (Wightman et
al., 1993), leading researchers to suspect a post-transcriptional method of regulation.
They determined that the lin-4 RNA sequence did not encode a protein, rather, they
identified two short, separate transcripts (the pre-miRNA and the mature miRNA
sequence), both of which were complementary to the 3‟ untranslated region (UTR) of the
lin-14 transcript. These results indicated that the translation of lin-14 was being repressed
by an antisense mechanism.
Seven years following the discovery of lin-4, a second short, regulatory, miRNA was
identified. Let-7 was found to direct the stages of C. elegans development in a mode
similar to that of lin-4 (Reinhart et al., 2000). It was reported that let-7 was evolutionarily
conserved from flies to humans, implicating a fundamental role for these genes in

2

animals (Lagos-Quintana et al., 2002; Pasquinelli et al., 2000). Interest in miRNAs
mushroomed after several laboratories revealed the presence of hundreds of miRNAs in
both plant and animal genomes (Bhat et al., 2005; Houbaviy et al., 2003; Lagos-Quintana
et al., 2001; Lau et al., 2001; Lee et al., 2001; Lim et al., 2003; Reinhart et al., 2002).
Evolution and conservation
It is believed that most miRNA genes originated from gene duplication events (Maher
et al., 2006), although incorporation of repetitive elements (Piriyapongsa et al., 2007),
local duplication, and mutation may have lead to the origin of miRNAs as well (Bentwich
et al., 2005; Zhang et al., 2007). Not only is the let-7 miRNA sequence conserved among
species, but the acquisition of let-7 is believed to have been an essential step of evolution
from lower metazoan to higher bilaterians (Pasquinelli et al., 2003). Recent studies have
revealed instances of miRNA evolution corresponding with introductions of
developmental complexity (Figure 1.1). Major miRNA acquisitions occur at branches
leading to vertebrates, placental mammals (Hertel et al., 2006), and primates (Bentwich et
al., 2005). It has also been observed that both flies and vertebrates have increased their
numbers of cell types in correlation with the acquisition of their respective number of
miRNAs (Sempere et al., 2006).
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Figure 1.1. Evolutionary acquisition of miRNAs
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Figure 1.1. Acquisition of miRNAs. Each node is characterized by the addition of at least
one new miRNA family and all metazoan lineages acquired at least one novel miRNA
family (number of families gained are shown in nodes at each branch). The x-axis
measures millions of years. There are at least four instances of a relatively high rate of
miRNA family acquisition, one at the base of bilaterians, one at the base of the
vertebrates, one at the base of eutherians, and one at the once at the base of primates
(Adapted, with modifications, from Niwa et al., 2007; Peterson et al., 2009).
Synthesis and function
Biogenesis
Genes encoding miRNA tend to be highly conserved among species and recent
estimates reveal that 60% of human protein-coding genes are under selective pressure to
conserve miRNA target sites (Friedman et al., 2009). MiRNAs are estimated to comprise
1- 5% of animal genes (Lim et al., 2003) and can be located within the introns (Fujita et
al., 2008; Rodriguez et al., 2004) or exons of mRNAs (as reviewed by Y. Zhao et al.,
2007). It has been observed that although miRNA genes are, on average, more frequently
located within the introns of long genes, their presence within introns of short genes
occurs at a higher frequency than expected by chance (Golan et al., 2010). MiRNA genes
tend to be clustered (Lagos-Quintana et al., 2001; Lau et al., 2001; Mourelatos et al.,
2002) and may contain their own promoters and enhancers (Fujita et al., 2008).
In the nucleus, miRNAs are transcribed by RNA polymerase II (RNA pol II), creating
primary miRNAs (pri-miRNA), which are several kilobases long (Borchert et al., 2006;
Cai et al., 2004; Lee et al., 2002). Pri-miRNAs are then processed by a Microprocessor
complex composed of the ribonuclease (RNase) III enzyme, Drosha, and an RNA binding
protein, Pasha, into a ~70 nucleotide (nt) pre-miRNA (Denli et al., 2004; Gregory et al.,
2004; Lee et al., 2003; Lee et al., 2002). The pre-miRNA possesses a 2 nt overhang on its
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3‟ end, which is recognized by Exportin-5, a GDP-dependent nuclear transmembrane
protein which allows for its transport out of the nucleus (Lund et al., 2004; Yi et al.,
2003).
In the cytoplasm, the pre-miRNA is processed by Dicer, an RNase III enzyme and the
trans-activator RNA (tar)-binding protein (TRBP) in mammals (Haase et al., 2005). Dicer
cleaves the pre-miRNA into a ~19- 24 bp double-stranded miRNA (ds-miRNA), of
which one strand is the guide strand (the strand with the weakest 5‟-end base pairing
(Tomari et al., 2004)) and the other is the passenger strand. The ds-miRNA is loaded into
a ribonuclear particle (RNP) complex, the RNA-induced silencing complex (RISC),
which is a group of proteins including Argonaute2 (Ago2), which cleaves the passenger
strand, discarding it (Matranga et al., 2005), and presents the mature miRNA to its
mRNA target (Faller et al., 2008).
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Figure 1.2. Synthesis of mature miRNAs

Figure 1.2. Pri-miRNA transcripts are processed into pre-miRNAs by an enzymatic
complex that includes the nuclear RNase III enzyme Drosha. The resulting pre-miRNA is
transported to the cytoplasm by Exportin-5. Once in the cytoplasm, pre-miRNAs are
processed into ~22-nucleotide duplexes by Dicer in association with TRBP. The strand
corresponding to the mature miRNA is subsequently loaded onto the RISC. Mature
miRNAs bind the 3'-untranslated region of target mRNAs and subsequently destabilize
them, block their translation, or, in rare instances, stimulate translation (Tili et al., 2008).
(Figure created by Dr. Scott Pratt and used with permission.)
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Naming
The Sanger miRBase Registry is an independent intermediary providing miRNA
sequence data, annotation, and predicted gene targets (Griffiths-Jones, 2004; GriffithsJones et al., 2006). MiRNAs may be submitted to the database after they are confirmed
via sequencing or a manuscript depicting their discovery is accepted for publication. The
first prefix of the miRNA name denotes the organism (ex. hsa= homo sapiens; ssc= sus
scrofa; mmu= mus musculus, etc), while the second indicates whether it is a mature
miRNA (i.e. miR) or a hairpin precursor (i.e. mir). The identifiers are assigned in
sequential numerical order. Orthologous miRNAs are assigned the same numerical
identifier (ex. hsa-miR-16 and ssc-miR-16) while paralogous sequences, those that only
differ by one or two nucleotides, are appointed letter suffixes (i.e. mmu-miR-19a and
mmu-miR-19b). When two miRNAs result from different arms of the same hairpin
precursor, the suffix „-3p‟ or „-5p‟ is added to indicate from which arm the mature
miRNA is excised. When two or more separate hairpins generate identical miRNAs, a
numbered suffix is added (i.e. ssc-miR-105-1 and ssc-miR-105-2). An asterisk indicates a
miRNA biogenesis by-product, such as the complementary non-miRNA arm of the
hairpin precursor. Exceptions to the standard miRNA annotation rules are the let and lin
families of miRNAs, in which the names were assigned based on their functions, prior to
the adoption of the current naming system.
Function
Generally, miRNAs regulate the translation of their mRNA targets at the posttranscriptional level. When a miRNA binds to its mRNA target with perfect
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complementarity, mRNA cleavage occurs (Bagga et al., 2005). This is the most common
mechanism of miRNA action in plants, but rarely occurs in animals (for exceptions, see
Yekta et al., 2004). Animal miRNAs imperfectly bind to their mRNA targets, thereby
inducing translational inhibition or repression (Bartel, 2004).
Previously, it was expected that miRNAs were capable only of down-regulating
protein production by inhibiting the translation of their mRNA targets, but the expression
and function of miRNAs is more complex than originally assumed. Another mechanism
for the down-regulation of gene expression by miRNAs was proposed by Wu et al.
(2006) who showed that miR-125b and let-7 imperfectly bind to targets in the 3‟ UTR
and reduce mRNA levels by expediting the deadenylation of the poly(A) tail, which leads
to mRNA decay. These results were supported when Wakiyama et al. (2007) established
that let-7 recruits micro-ribonucleoprotein (microRNP) complexes containing Ago to
direct the deadenylation of target messenger RNAs. In Arabidopsis, there is evidence that
miRNA interacts with newly transcribed messenger RNA to alter the chromatin state of
corresponding mRNA template DNA, affecting methylation of downstream coding
sequences (Bao et al., 2004); however, its effects were not determined, nor was this
validated in animals.
To complicate issues, miRNAs may additionally up-regulate the production of
proteins through different mechanisms. Using serum-starved cells, Vasudevan et al.
(2007) demonstrated that miR-369-3p up-regulated the translation of tumor necrosis
factor alpha (TNFα) when Ago2 and fragile-X-mental retardation related protein 1
(FXR1) were associated with AU-rich elements (ARE) in the 3‟UTR of TNFα mRNA.
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They found that, during cell cycle arrest, the ARE were transformed into a translation
activation signal that recruited factors associated with the miRNA machinery,
microRNPs. Next, they showed that let-7 oscillated between translational repression and
activation of its target, high-mobility group AT-hook 2 (HMGA2), in synchronization
with the cell cycle. The exact mechanism is unknown and the authors suggested that
miRNA translational repression is a property of proliferating cells.
Place et al. (2008) identified target sites for miR-373 within the promoters of Ecadherin and cold-shock domain-containing protein C2. Transfection of pre-miR-373 and
miR-373 induced the expression of both proteins and also increased RNA pol II at their
transcription start sites. Orom et al. (2008) discovered that, while miR-10a caused
translational repression upon binding to its target in the 3‟ UTR of Ras-related nuclear
protein (Ran) and Penicillin-binding protein 1 (Pbp1), it also bound to the 5‟ UTR of
mRNA encoding ribosomal proteins and enhanced their translation during amino acid
starvation. Although the precise process is unknown, the authors hypothesized that miR10a competes with an inhibitory factor that binds downstream from the 5‟ regulatory
motif.
Another study suggested an epigenetic role of miRNAs in embryonic development.
Grandjean et al. (2009) noticed that the microinjection of miR-124 into mouse zygotes
resulted in increased embryonic growth rates and pups exhibiting a „giant‟ phenotype,
which was heritable over several generations. qRT-PCR showed that, following
microinjection, miR-124 levels quickly returned to the basal level of the controls, but
Sox9 (SRY (sex determining region Y)-box 9), which has high sequence homology to
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miR-124, showed a significant increase in the microinjected embryos. Sox9 is a
transcription factor known for its role in embryo growth and proliferation of various
organs. The researchers theorized that exposure of embryos to miR-124 resulted in a
change to the chromatin structure of the Sox9 promoter.
Other small RNAs
Aside from miRNAs, there are other classes of small, non-coding RNAs in mammals
which are due mention (Figure 1.3). Small nuclear RNA (snRNA) are associated with a
protein complex called a small nuclear ribonucleoprotein (snRNP or “snurps”) complex
that are involved in RNA splicing and telomere maintenance. Small nucleolar RNAs
(snoRNAs) are found in the nucleus and Cajal bodies and have a role in RNA synthesis
by guiding modifications of rRNAs and tRNAs. Short, interfering RNA (siRNA) are 2025 bp double-stranded RNA involved in RNA interference. siRNAs originate from long
exogenous or endogenous dsRNA molecules, while miRNAs are synthesized from
endogenous transcripts that form local hairpin structures. Piwi-interacting RNA (piRNA)
is a large class of small RNAs that form interactions with Piwi proteins. The functions
and biogenesis of piRNAs are still being elucidated but they have been shown to be
testes-specific in mammals (Houwing et al., 2007), generating much interest in their
potential roles in spermatogenesis (Aravin et al., 2006).
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Figure 1.3. Classes of mammalian RNA
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Figure 1.3 shows the different groups of coding and non-coding RNA present in
mammals (adapted, with modifications, from Buckingham, 2003).
Target prediction
Unlike plant miRNAs, which bind with perfect complementary to their mRNA targets,
animal miRNAs are not completely complementary, rather animal miRNAs contain a
seed sequence which must bind to the mRNA target. The seed sequence (Figure 1.4)
usually encompasses bases 2- 7 from the miRNA 5‟ end (Lewis et al., 2005). Bulges are
frequently noted between positions 9 and 14 and may be essential for miRNA function or
target recognition (Brennecke et al., 2003; Johnston et al., 2003; Vella et al., 2004). The
seed region was first identified using bioinformatic analysis as the only consistent region
of miRNAs that retrieved more evolutionarily conserved complementary target sites than
expected by chance (Lewis et al., 2003). Introduction of mutations into the seed region of
a presumed miRNA-mRNA duplex may provide experimental target site validation.
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Figure 1.4. Binding of a miRNA molecule to its messenger RNA target

Figure 1.4 illustrates the complementary binding of a miRNA‟s seed sequence to its
mRNA target, while the non-seed region may contain mismatches and bulges.
Not surprisingly, it has been experimentally validated that some miRNAs use nonseed sites in addition to seed-type target sites (Ha et al., 1996; Reinhart et al., 2000) and
that GU wobble pairs in the seed region may be tolerated (Didiano et al., 2006; Johnston
et al., 2003). A human cytomegalovirus has been shown to generate a miRNA that uses
non-seed targeting to repress a major histocompatibility complex-related gene, thus
evading destruction by the host‟s immune system (Stern-Ginossar et al., 2007). Further
explorations to illuminate the complexities of mRNA target recognition by miRNAs are
warranted.
A single gene may be targeted by multiple miRNAs (Ambros, 2003; Reinhart et al.,
2000; Vella et al., 2004), of which some target sites may overlap (Doench et al., 2004),
and a single miRNA may target multiple genes. Target sequences may be conserved or
non-conserved and those genes with non-conserved target sites tend to be expressed in
tissues lacking the corresponding miRNA, i.e- conserved sites are generally present in
genes that are co-expressed with the miRNAs by which they are targeted (Farh et al.,
2005). Mammalian-specific miRNAs have fewer conserved targets than those miRNAs
conserved more broadly (Friedman et al., 2009).
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TargetScan was the first algorithm developed to identify targets of vertebrate miRNAs
(Lewis et al., 2003) and combines thermodynamics-based modeling of RNA- RNA
interactions with comparative sequence analysis to predict phylogenetically conserved
matches between miRNA seed sequences and 3‟UTRs. Results are returned as a ranking
by the number of predicted target sites present on each 3‟ UTR. Many other target
prediction servers and databases have been developed, a few of which are described here:
miRanda (John et al., 2004) is based on the alignment of miRNAs with their projected
targets, with scores based upon complementary pairing between the seed region and the
mRNA target and a calculation of binding energy; no targets without a perfect seed match
will be found. miRBase (Grun et al., 2005) and microRNA.org both utilize the miRanda
algorithm with modifications. miRBase allows predictions for all species in Ensemble
(www.ensembl.org) and provides a P-value for each predicted interaction, whereas
microRNA.org does not require a perfect seed match, but does not provide P-values.
PicTar (Krek et al., 2005) calculates the hybridization energy between the whole miRNA
and the mRNA target and the likelihood that a transcript is regulated by two or more
miRNAs in combination. It cannot find targets without perfect seed match. RNAhybrid
(Rehmsmeier et al., 2004) determines the lowest free energy hybridization between two
RNA molecules (i.e. most stable binding site of a miRNA on a mRNA) and allows
parameters to be set by the user. DIANA-microT (Maragkakis et al., 2009) is an
algorithm based on several parameters calculated individually for each microRNA and it
combines conserved and non-conserved microRNA recognition elements into a final
prediction score. The MAMI server and database (meta mir: target inference;
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http://mami.med.harvard.edu/) is unique in that it provides a composite prediction of
target genes from five independent target prediction tools: TargetScan, miRanda,
DIANA-microT, miRtarget, and picTar. MAMI also accommodates miRNA lists, rather
than a single miRNA search, and allows for sensitivity and specificity to be predefined by
the user.
Regulation of miRNA expression
The mechanisms underlying miRNA regulation are still being elucidated. Microarray
profiling studies have shown that expression patterns of some miRNAs can be attributed
to regulatory sequences in their promoters (Barad et al., 2004; Calin et al., 2004; Liu et
al., 2004; Sempere et al., 2004). MiRNAs located within the introns of their host genes
can be transcribed along with their host and will exhibit the same patterns of expression
(Bartel, 2004; Rodriguez et al., 2004). Fontana et al. (2007) demonstrated a negative
feedback loop of miRNA action, in which miRNAs 17-5p, -20a, and -106a down-regulate
the translation of acute myeloid leukemia-1 (AML1) which, in turn, binds the promoters
of these miRNAs, inhibiting their transcription. Kedde et al. (2007) showed that an RNAbinding protein, dead end 1 (Dnd1) binds to miRNA target sites thereby preventing
miRNA binding.
The first indication that hormones may regulate miRNA expression was elucidated by
Sempere et al. (2002; Sempere et al., 2003), who showed that, in Drosophila, the steroid
hormone ecdysone (20-hydroxyecdysone), along with the ecdysone-inducible gene
Broad-Complex, is required for the expression of let-7. Bethke et al. (2009) demonstrated
a hormone-mediated regulatory mechanism of let-7a in C. elegans. The nuclear receptor
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DAF-12 regulates developmental progression in response to the environment. In
favorable environments, steroid ligands bind to the DAF-12 nuclear receptor, initiating
development into the next larval stage. In unfavorable conditions, ligands were
suppressed and DAF-12 repressed miRNA expression which led to developmental arrest.
Estrogen and the estrogen receptor, ERα, have also been shown to play an elaborate role
in miRNA activity, as they can be both mediators of miRNA transcription (Cohen et al.,
2008; Lowery et al., 2009; Macias et al., 2009; Maillot et al., 2009) and may be regulated
by miRNAs (Adams et al., 2007; Castellano et al., 2009).
Obernosterer (2006) discovered that miRNA expression can also be regulated posttranscriptionally and in a tissue-specific manner. The researchers studied miR-138, which
is considered to be a brain-specific miRNA. Surprisingly, they found that the miR-138
precursor was present in all tissues and cells analyzed, while the mature form was found
in only the cerebrum, cerebellum, and midbrain, as expected. They hypothesized that the
export of pre-miR-138 from the nucleus was impaired in all tissues except the brain,
which would prevent it from processing by Dicer; however, northern blot analysis of
cytoplasmic RNA showed that pre-miR-138 is effectively transported to the cytoplasm.
The authors then tested an activator model in which an activating agent produced only in
the brain allowed for pre-miR-138 processing. This theory was dismissed through the
observation that a recombinant Dicer protein was still able to process pre-miR-138 in
vitro. Finally, the group added increasing amounts of cytoplasmic extracts which
abolished processing of pre-miR-138 by Dicer. This observation led researchers to favor
the presence of an inhibitory factor which binds miR-138, thereby preventing its
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processing by Dicer. The processing of other miRNAs was unaffected by titrating
increasing amounts of cytoplasmic extracts. Following Obernosterer‟s discovery, other
groups also identified and confirmed examples of post-transcriptional regulation of
miRNAs (Thomson et al., 2006; Viswanathan et al., 2008; Wulczyn et al., 2007; Zhang et
al., 2009).
At least two studies have shown that components of developmental signaling
pathways may control miRNA expression. Sweetman et al. (2006) showed that fibroblast
growth factor- mediated signaling negatively regulated the transcription of miR-206 in
chickens. Other researchers showed that Oct4 and Sox2, transcription factors required for
pluripotency, bind to the promoter region of miR-302, a cluster of miRNAs specifically
expressed in embryonic stem cells (ESCs) and pluripotent cells. MiR-302a was shown to
repress the translation of cyclin D1, an important G1 regulator (Card et al., 2008).
Roles in reproduction
Testicular and sperm miRNAs
Studies have shown that, in humans, the amount of total RNA in normal spermatozoa
is greater than the amount of RNA in non-motile sperm (Roudebush et al., 2004) and less
than the amount of RNA in morphologically abnormal sperm (Wild et al., 2000).
Ostermeier et al. (2005a) suggested that stable RNAs could be useful for male infertility
prognosis and specific male infertility factors may be identified using genomic profiling
of spermatozoa. Ostermeier et al. (2002) also proposed that spermatozoa mRNA profiling
could be used to generate genetic fingerprint of normal, fertile men. Miller et al. (1994)
suggested that spermatozoa mRNAs are remnants of untranslated stores, “providing a
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historic record or fingerprint of spermatogenesis”. The literature described indicates that
sperm RNA, likely to include miRNAs, may contribute to spermatogenesis, sperm
fertilization capacity, and/ or early embryonic development. It is evident that miRNA are
involved in the production of sperm and that their overabundance or absence in mature
sperm could be indicative of aberrant development, function and/or fertility.
Review of spermatogenesis
Mammalian spermatogenesis is the process of the production of mature spermatozoa
from spermatogonial cells and can be divided into spermatocytogenesis and
spermiogenesis (Figure 1.5). During spermatocytogenesis, mitotic divisions allow
spermatogonial renewal while meiotic divisions give rise to primary spermatocytes,
secondary spermatocytes, and finally, haploid spermatids. Following meiosis, histones
are replaced by transition proteins, which are later replaced by protamines, allowing for
chromatin compaction. Spermiogenesis involves morphological changes such as nuclear
condensation, acrosome formation, cytoplasmic reorganization, and development of
flagella. It is generally agreed that sperm cells are transcriptionally silent due to their
tight chromatin compaction, so any RNA (or miRNA) present is likely a result of
spermatogenesis, supporting the statements of Miller et al. (1994). In the mouse,
transcription ceases at the transition from round to elongating spermatids, before the
completion of spermiogenesis (as reviewed by Braun, 1998). In haploid germ cells,
approximately two thirds of messenger RNAs are stored in mRNA ribonucleoprotein
particles (mRNPs), which are translationally inactive (Kleene, 1993; Schmidt et al.,
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1999). Various genes and proteins have been identified as molecular markers of sperm
fertility (Muratori et al., 2009), alluding to much opportunity for miRNA regulation.
Another class of small RNAs has also recently attracted attention for its potential role
in spermatogenesis. Piwi-interacting RNAs (piRNAs) are slightly larger than miRNAs
(~25- 35 nt) and exhibit both tissue-restricted and abundant expression in the mammalian
testis (Houwing et al., 2007; Kim, 2006). piRNAs associate with members of the Piwi (Pelement wimpy testis-induced) protein family (Aravin et al., 2006; Girard et al.,
2006).The Piwi proteins are a subfamily of the Argonaute proteins and it has been shown
that ablating specific members of the Piwi family results in a block in spermatogenesis at
different arrest points depending on which member has been ablated (Deng et al., 2002;
Kuramochi-Miyagawa et al., 2004). Both the biogenesis of piRNAs and their exact
function remain to be elucidated. It has been estimated that approximately one million
piRNA molecules exist per spermatocyte or round spermatid (Aravin et al., 2006).
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Figure 1.5. Mammalian spermatogenesis.
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Figure 1.5 illustrates the process of spermatogenesis, the production of mature haploid
spermatozoa from diploid spermatogonial cells. Spermatogenesis is divided into two
phases: spermatocytogenesis and spermiogenesis.
Testicular miRNAs
There is compelling evidence that miRNAs are imperative for spermatogenesis.
Studies have demonstrated that testicular miRNA profiles change during development
and puberty (Barad et al., 2004; Yan et al., 2009; Yu et al., 2005). Barad et al. (2004)
showed that miR-34b expression is significantly higher in adult mouse testis than in
prepubertal mouse testis, implicating a possible role of miRNAs in the differentiation of
male germ cells. Using a cloning method, Ro et al. (2007a) identified 141 miRNAs in
mouse testis, six of which were testis-specific. Mice lacking Dicer1 have
morphologically abnormal elongating spermatids with low motility and are usually
infertile (Maatouk et al., 2008), indicating that Dicer1 and miRNA play crucial role in
spermatogenesis. Lian et al. (2009) found differential miRNA expression profiles of
testes from patients with non-obstructive azoospermia versus normal controls: 154 were
down-regulated while 19 were over-expressed, again suggesting a role of miRNAs in
regulating spermatogenesis.
Using prepubertal and adult mouse testis, Yu et al. (2005) showed that miR-122a
targets mRNA levels of transition protein 2 (Tnp2), a nuclear protein that is synthesized
only in round spermatids and stored for translation toward the end of spermatogenesis.
They demonstrated that miR-122a reduced the levels of Tnp2 messenger RNA activity
(via luciferase assay). This observation suggests a role of miR-122a in the regulation of
the expression of proteins which are required for the chromatin condensation process
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occurring in the post-meiotic germ cells. The same study also demonstrated that testicular
miRNAs show different developmental patterns of expression. Yan et al. (2007) found
that 14 miRNA were up-regulated and 5 were down-regulated in immature mouse testis
compared to adult testis. Using microarray profiling, Yan et al. (2009), discovered
differences in the expression of 26 miRNAs in immature vs. mature rhesus testis samples,
some of which are predicted to target genes involved in spermatogenesis.
Sperm miRNAs
An unabridged review of miRNAs identified in the male gamete is a short one.
Ostermeier (2005b) used a microarray system to identify 68 small RNAs in human
spermatozoa, at least one of which was a known human miRNA (miR-182). Kotaja et al.
(2006) used in situ hybridization to demonstrate the presence of four miRNAs plus Dicer
and Ago2 in the chromatoid bodies of murine haploid germ cells. Amanai et al. (2006)
and Yan et al. (2008) detected miRNAs (n= 54 and n= 28, respectively) in mouse sperm
using PCR methods, although Amanai and colleagues predicted a few hundred more via
miRNA microarrays.
Amanai et al. (2006) injected mature mouse sperm with miRNA inhibitors against five
endogenous sperm miRNAs and allowed them to fertilize via IVF. They found no effects
of inhibiting these five miRNAs (miR-16, -30c, -145, -191, and -222) on fertilization
capacity or early embryonic development. Interestingly, miR-16 initially was reduced but
then showed increased levels after 24 h, possibly suggesting de novo miR-16 gene
transcription or precursor processing in the mature sperm.
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Role of sperm RNA in fertilization and embryonic development
Although sperm messenger RNAs previously have been thought to play a negligible
role in fertilization and early embryonic development, both paternal messenger RNAs
and miRNAs are delivered to the oocyte at fertilization (Amanai et al., 2006; Ostermeier
et al., 2004). There is also evidence that sperm messenger RNA can affect the phenotype
of the resulting offspring. Rassoulzadegan et al. (2006) reported that sperm from male
mice carrying a Kit mutation can deliver the messenger RNA transcripts derived from the
mutant Kit allele into the oocytes during fertilization, causing the offspring to display a
mutant white spot phenotype. If sperm messenger RNA can affect the resulting offspring,
it is conceivable that sperm miRNA may influence embryo physiology as well. McCallie
et al. (2010) detected aberrant embryo miRNA expression from human blastocysts
generated from patients with male factor infertility compared to blastocysts produced
from normal control males, although the authors did not examine the miRNA profiles of
the sperm used.
Ovarian miRNAs
Addressing female physiology, many studies have examined the expression and
influence of miRNAs in ovary, with recent interest in the role of miRNAs in ovarian
cancer (Bendoraite et al., 2010; Dahiya et al., 2008; Shen et al., 2010). In 2006, a
computational analysis of the pig genome predicted 58 miRNAs and northern blot
analysis confirmed the expression of two (miRs-31 and -92) within the porcine ovary
(Kim et al., 2006). Ro et al. (2007b) used a cloning technique to identify miRNAs
expressed in the ovaries of 2 wk old and adult mice, discovering a total of 122 miRNAs
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from whole ovaries. Choi et al. (2007) examined miRNA expression levels in the
newborn mouse ovary and the effects of knocking down the Nobox transcription factor
required for oocyte differentiation and survival. One hundred seventy-seven miRNAs
were identified in the newborn ovary and four were found to decrease ~2 fold in the
Nobox-/- ovaries (let-7d, miR-346, -699, and -801). In all of these studies, whole ovarian
tissue was used and the stage of the estrous cycle of the adult ovaries was unknown.
Recent studies demonstrated that Dicer1 is required for normal ovarian function
(Otsuka et al., 2007; Otsuka et al., 2008). A murine Dicer1 hypomorph (Dicer1d/d) was
constructed, which resulted in a ~75% loss of Dicer1 messenger RNA levels.
Transplantation of wild type ovaries into Dicer1d/d females resulted in live offspring, but
wild type females transplanted with Dicer1d/d ovaries failed to establish pregnancies,
indicating that the fertility defect was inherent to the ovary. Further analysis of Dicer1d/d
mice showed that the mice ovulated normally and the ova were fertilized and continued
to undergo the first embryonic cell division. The researchers then examined the
vasculature of the corpus luteum (CL) in Dicer1d/d mice and found a decrease in the
amount and length of the blood vessels, which correlated with the upregulation of tissue
inhibitor of metalloproteinases 1 (Timp1), an anti-angiogenic factor. MiRNA-17-5p and
let-7 regulate Timp1 expression and their loss in Dicer1d/d mice was hypothesized to
cause the reduction in angiogenesis. Knockdown of miR-17-5p and let-7 in wild type
mice reduced CL angiogenesis and decreased serum progesterone levels. Injection of
miR-17-5p and let-7 into the ovarian bursa of the Dicer deficient mice restored CL
angiogenesis, increasing the level of progesterone; however, subsequent pregnancies
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were not maintained, indicating that other ovarian miRNAs play a crucial role (Yang et
al., 2005).
Toloubeydokhti et al. (2008) correlated the expression of specific miRNAs to the
expression levels of their target messenger RNA in follicular cells collected from women
undergoing ovarian stimulations to overcome fertility problems. The researchers
examined miRNAs involved in the estrogen (E2) biosynthesis pathway, miRs-17, -211, 542, and -23b, along with their respective targets: steroidogenic acute regulatory protein
(StAR), cytokine IL-1b, Cox-2, and aromatase (CYP19A1). They found that the
expression levels of miRs-17, -211, and -542 were inversely correlated to the messenger
RNA expression levels of StAR, IL-1b, and Cox-2 while a higher expression of miR-23b
was directly correlated to higher CYP19A1 messenger RNA expression levels when
compared to healthy controls undergoing ovarian stimulation. This study did not measure
proteins encoded by the messenger RNA of interest.
In vitro studies of ovarian cell cultures have shown differences in miRNA expression
in response to hormonal treatment. Fiedler et al. (2008) treated murine granulosa cells
with human chorionic gonadotropin (hCG) and found that thirteen miRNAs were
differentially expressed. Three were up-regulated and ten were down-regulated between 0
h and 4 h post-hCG. MiR-132, which has been shown to be transcriptionally regulated by
cAMP (Vo et al., 2005) was up-regulated. Interestingly, miR-132 has been shown to
post-transcriptionally regulate co-repressor C-terminal binding protein (Klein et al.,
2007), a protein recently exhibiting the ability, along with steroidogenic factor-1, to
regulate adrenal steroidogenesis (Dammer et al., 2008).
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Because miRNAs play a vital role in cell differentiation events, it is likely that defects
in the regulatory control of specific miRNAs can result in abnormal folliculogenesis,
cystic ovaries due to an anovulatory state, and pregnancy loss due to CL insufficiency.
While it has been demonstrated that miRNAs show altered expression in ovarian cancer
and other non-malignant pathologies, the normal ovarian miRNA profile throughout the
estrous [or menstrual] cycle has not been described. It is highly likely that the changes in
cell proliferation, hormone receptor expression, apoptosis, and steroidogenesis that occur
on and within the ovary throughout the estrous cycle are caused, in part, by posttranscriptional gene regulation.
Oocyte miRNAs
Whereas spermatozoa are considered to be transcriptionally dormant, immature
oocytes exhibit a high level of mRNA production, crucial for the production of proteins
required for maturation of the oocyte and support of the early embryo (Wassarman et al.,
1992). A high rate of transcription also creates the prospect for a high degree of
transcriptional regulation. Tang et al. (2007) found dynamic changes in miRNA
expression in immature versus mature murine oocytes. They next deleted Dicer from
maturing oocytes and observed that miRNA biogenesis was blocked, a finding which was
further investigated by Murchison et al. (2007), who demonstrated that Dicer is required
for meiotic spindle integrity and completion of meiosis I. Aside from mice, miRNAs
have been identified in the mature and immature oocytes of a few other species, including
bovine (Tesfaye et al., 2009; Tripurani et al., 2010), Drosophila (Nakahara et al., 2005),
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and Xenopus (Watanabe et al., 2005). To date, no studies have investigated the presence
of miRNAs in porcine oocytes.
Embryonic miRNAs
Bernstein et al. (2003) demonstrated that the ablation of Dicer1 in mice was
embryonic lethal, suggesting a critical role for miRNA in early embryonic development.
Houbaviy et al. (2003) identified embryonic stem (ES) cell-specific miRNAs, a cluster
that was not detected in differentiated ES cells or adult tissues. Mineno et al. (2006)
detected 390 miRNAs in mouse embryos using massively parallel signature sequencing
(deep sequencing) and also showed temporal expression profiles of specific miRNAs.
Using high throughput pyrosequencing, it has been estimated that there are 110,000
miRNA transcripts per murine embryonic stem cell (Calabrese et al., 2007). Tesfaye et al.
(2009) investigated the expression patterns of six miRNAs during bovine preimplantation development. Using pools of 10- 100 in vitro produced embryos from
oocyte to blastocysts stages, qRT-PCR results showed highly variable trends in miRNA
expression (Figure 1.6). Giraldez (2006) showed that zebrafish miR-430 not only
regulates several hundred mRNAs, but also accelerates the deadenylation and clearance
of maternal mRNAs during the shift to zygotic transcription. This has not yet been
reported in any mammalian system.
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Figure 1.6. Expression profiles of six miRNAs during early bovine embryo
development
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Figure 1.6 shows the capricious expression profile of six miRNAs in six stages of bovine
pre-implantation development. Adapted from Tesfaye et al. (2009).
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Assisted reproductive technologies
Assisted reproductive technologies (ART) such as in vitro fertilization (IVF), embryo
transfer (ET), and intracytoplasmic sperm injection (ICSI) are used in both human
fertility treatments and in the livestock industry, whereas somatic cell nuclear transfer
(SCNT) is reserved mainly for livestock, niche markets, and research. Although these
techniques are invaluable with regards to managing infertility and maximizing genetic
gain in animal agriculture, research has demonstrated that embryos produced via ART
often exhibit aberrations in development, including epigenetic defects (DeBaun et al.,
2003; Gicquel et al., 2003; Maher et al., 2003; Moll et al., 2003; Orstavik et al., 2003),
chromosomal abnormalities (Hyttel et al., 2000b), actin filament disorganization (Wang
et al., 1999), nucleolar-related proteins defects (Bjerregaard et al., 2004; Hyttel et al.,
2000a) and even disruptions in lipid content (Romek et al., 2010).
Kikuchi et al. (2004) examined the effect of in vitro maturation (IVM) on porcine
oocytes, followed by IVF and either immediate ET, ET after two days of culture, or ET
after six days of culture. Of the embryos that were immediately transferred into a
recipient, 37% developed to the blastocyst stage, whereas those that were cultured for
two or six days had a 5% and 20% blastocyst rate. Next, the researchers examined the
effect of in vitro culture on reaching the fetal stage of development. They performed IVF
on IVM oocytes and either transferred the embryos immediately, after 24 h of culture, or
after 48 h of culture. Those that were immediately transferred resulted in 6.7% fetal
development, whereas those that were cultured for 24 or 48 h resulted in 1.7% or 2.0%,
respectively. These results indicated that in vitro conditions were inadequate for optimal
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embryo development. Machaty et al. (1998) examined the effects of embryo culture on
porcine pre-implantation embryos. They collected in vivo fertilized embryos at the zygote
or 2-cell stage, cultured them for four days, and compared them to embryos allowed to
mature in vivo. The cultured embryos had lower nuclear numbers and a lower ratio of
inner cell mass to trophectoderm nuclei than the in vivo matured embryos (P < 0.001).
Using whole genome microarrays, Jones et al. (2008) compared gene expression
between in vivo and in vitro matured oocytes and found that the IVM oocytes expressed
over 2000 genes at > 2-fold higher levels than the in vivo matured oocytes, 162 of which
were expressed at 10-fold or greater levels. Another group used small amplified RNAserial analysis of gene expression to compare global gene expression patterns from in
vivo versus in vitro produced porcine embryos (Miles et al., 2008) and detected 938
transcripts that were differentially expressed, suggesting significant aberrations in IVF
embryos. Next, using bioinformatic resources, they categorized the mis-expressed genes
into functional groups, discovering that they were involved in biological processes
including cellular metabolism, organization, and response to stress. Suboptimal culture
conditions have been attributed to oxygen concentration (Goto et al., 1993; Yang et al.,
1998), gonadotropin levels, including LH, FSH, and hCG, and epidermal growth factors
(Akaki et al., 2009).
Methodologies to detect miRNA
Microarrays
Commercially available miRNA arrays were developed (Ambion, Austin, TX;
(Shingara et al., 2005)) and microarray procedures allow for the identification of specific
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miRNA expression in various tissues (Barad et al., 2004; Bentwich et al., 2005). While
most miRNA arrays are generated from human and rodent miRNA sequences, at the
commencement of these studies, no information was available for the efficacy of using a
commercial array in cross-species hybridizations. Many miRNAs exhibit high
conservation among species; however, when using cross species microarrays, failure to
detect 100% of miRNAs due to sequence mismatches at hybridization should be
assumed. Because there are only ~1000 known miRNAs, an entire “miRNAome” can be
identified on a single chip, in triplicate; however, a major drawback of microarray
technology is the inability to discover novel miRNA sequences.
Deep sequencing
Next Generation pyrosequencing, also known as deep sequencing, allows for whole
transcriptome sequence determination, including small RNAs. Deep sequencing
overcomes many of the disadvantages inherent to microarrays in that it allows for
measurement of absolute abundance and is not limited to previously known sequences.
There are several tools available for analyzing the miRNA transcriptome information
resultant of deep sequencing: miRDeep (Friedlander et al., 2008), miRExpress (Wang et
al., 2009), SeqBuster (Pantano et al., 2010), miRanalyzer (Hackenberg et al., 2009), and
deepBase (Yang et al., 2010).
Northerns
Northern blotting allows for the detection of a particular miRNA or miRNA precursor
of interest within a sample of RNA (Grimm et al., 2006; Varallyay et al., 2008). Total
RNA is first separated by size via denaturing gel electrophoresis and then blotted onto a
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membrane. A labeled probe complementary to the miRNA sequence of interest is
allowed to hybridize and, if the sequence of interest is present, the probe will bind and
detection may occur. A shortcoming of northern blotting is that a large quantity of RNA
is required, which renders this technique ineffective for the detection of miRNAs in
samples of limited RNA template, such as embryos.
miRNA inhibition
The practice of inhibiting or „knocking down‟ miRNAs mimics the ablation/
replacement studies historically used to study endocrinology and the effects that the
presence, or absence, of hormones had on tissues and systems. At the molecular level,
many techniques do not require the permanent ablation of a gene or pathway; rather, its
deletion can be conditionally induced in tissues of interest. Anti-microRNAs are
chemically modified, single stranded, oligonucleotide analogs complementary to either
the mature miRNA or its precursors, which can be used either in vivo or in vitro to inhibit
the action of an endogenous miRNA. Commercially available anti-miRNAs are available
(Anti-miR™ miRNA Inhibitors; Ambion) that may be injected for in vivo studies or
transfected or electroporated into cells in vitro to allow for the study of the biological
effects of specific miRNA.
RT-PCR
To address the shortcomings of northern blotting methodologies for miRNA detection,
investigators developed PCR-based technologies for miRNA identification. First
attempts at RT-PCR detected the larger miRNA precursors prior to cleavage by Drosha
and/or Dicer (Schmittgen et al., 2004). While effective, debate arose over whether it
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directly corresponded to the expression of mature miRNA. Because miRNAs are
approximately the same size as traditional PCR primers, it was necessary to modify
methods to detect mature miRNA (Chen et al., 2005; Shi et al., 2005; Tang et al., 2006).
Ambion‟s (Austin, TX) mirVana microRNA qRT-PCR kit utilizes primers that bind to
the 5‟ and 3‟ ends of mature miRNA sequences and contain a 28 or 38 nt overhang which
function as stabilization sequences (Figure 1.7). The resulting product is ~85- 89 bp in
length, depending on the size of the miRNA.
Figure 1.7. mirVana miRNA primer structure

Figure 1.7 shows the stabilization sequence on Ambion‟s miRNA primers. The result is
an 85- 90 bp product containing the 19-24 miRNA sequence flanked by 38 bp from the
RT primer and 28 bp from the PCR primer.
The Taqman® miRNA detection system (Applied Biosystems, Foster City, CA)
exploits the 5'-3' exonuclease activity of the Taq polymerase, which results in cleavage of
fluorescent dye-labeled probes during the primer extension step of PCR (Figure 1.8). The
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system includes forward primers, stem-loop reverse primers and a Taqman probe which
binds to an internal site on the sequence of interest. The Taqman probe is attached to two
fluorescent tags, one of which is a reporter dye (6-carboxyfluorescein or FAM) that has
its emission spectra quenched when in close proximity to the second fluorescent dye, 6carboxy-tetramethyl-rhodamine (TAMRA). When Taq polymerase degrades the Taqman
probe, FAM is released from the quenching activity of TAMRA and emits fluorescence
proportional to the amount of PCR product formed.
Figure 1.8. Taqman miRNA primer structure

Figure 1.8 illustrates Applied Biosystem‟s stem-loop reverse primers for miRNA
detection and the structure of the Taqman probe.
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The normalization nightmare
With emerging insights into miRNA expression and regulation, data normalization for
miRNA expression studies presents a challenge. Reviews of the literature unveil
inconsistent methods in the normalization of miRNA gene expression as measured by
qRT-PCR. The purpose of normalizing data is to reduce technical variation within
datasets. An optimal housekeeping gene (also referred to as normalization gene, internal
control, standard, or endogenous control), is a single nucleic acid that is invariantly
expressed across all samples, is expressed with the target in the cells of interest, and that
demonstrates equivalent storage stability, purification properties, and quantification
efficiency as the target of interest (Peltier et al., 2008). At least five normalization
schemes can be identified in the literature:
1) traditional housekeeping gene. These gene products are typically needed for
maintenance of the cell and are not expected to change in response to treatment or
experimental conditions. Traditional and frequently used housekeeping genes
include glyceraldehyde-3-phosphate dehydrogenase (GAPDH), actins, tubulins,
ribosomal RNAs, and ubiquitin; however, their expression has been shown to be
regulated due to treatment (Foss et al., 1998; Schmittgen et al., 2000) and, due to
their larger size, may not exhibit the same extraction properties as smaller RNAs.
2) other small RNA. It has been suggested that small RNAs, such as nuclear and
nucleolar RNA, may better mirror miRNAs in extraction efficiency than larger
mRNAs and so are often used as normalization factors. However, U6, a small
nuclear RNA, and 5S, a ribosomal RNA which is transcribed by RNA pol III (most
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miRNAs are transcribed by RNA pol II), were shown to be poor reference genes for
miRNA expression in both normal and cancerous human tissues (Peltier et al.,
2008). Davoren et al. (2008) examined the expression of three small nucleolar
RNAs (RNU19, RNU48, and Z30) along with five miRNAs for use as endogenous
controls across malignant, benign, and normal breast tissue and found certain
miRNAs to be more stable than the small RNAs under scrutiny.
3) ubiquitously expressed miRNA. Liang et al. (2007) characterized 345 miRNAs in
40 normal human tissues. Fifteen miRNAs were universally expressed at
comparable levels in all tissues examined, based upon their Ct values and Ct
variations. The authors recommended the use of these miRNAs as universal
reference candidates in which to normalize miRNA expression. Ro et al. (2007a)
found that miR-16 was evenly and abundantly expressed in murine testes,
spermatocytes, and spermatids and suggested using miR-16 as a housekeeping
miRNA gene.
4) more than one stably expressed gene/ miRNA. Some researchers recommend the
use of more than one housekeeping gene to further mask technical variation
(Andersen et al., 2004; Pfaffl et al., 2004; Szabo et al., 2004; Vandesompele et al.,
2002). While attractive in theory, it results in effectively doubling the number of
required PCR reactions if interested in examining only a handful of miRNAs.
5) Vandesompele/ Mestdagh method. This group profiled 18 small RNA controls,
along with 430 miRNAs, in 147 samples from five human tissues. They assessed
the use of the geometric mean of all expressed miRNAs in a given sample as a
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normalization factor. They then compared this method to an alternate approach of
using one or two small RNA controls, including three previously proposed
universal reference miRNAs. Using geNorm software (Vandesompele et al., 2002),
they showed that the geometric mean was ranked highest with regards to expression
stability and resulted in an adequate reduction in technical variation, as measured by
the CVs of normalized expression values (Mestdagh et al., 2009). This method is
not appropriate for smaller profiling studies, nor would it be suitable for miRNAs
that are clustered or co-regulated, as the mean would undoubtedly be swayed.
In summary, the rules for choosing a gene(s) to use as a normalization factor for
miRNA expression analysis remain unresolved. BestKeeper (Pfaffl et al., 2004),
Normfinder (Andersen et al., 2004), and geNorm (Vandesompele et al., 2002) are all
local software tools useful for the analysis of candidate reference genes: no differences
have been found between these tools (Spinsanti et al., 2006; Willems et al., 2006).
Why pigs?
In addition to their obvious role in the food chain, pigs are an important model for
biomedical research. Pigs and humans share similarities in their physiology,
biochemistry, pathology, and pharmacology and, evolutionarily, pigs are closer than mice
to humans (Gorodkin et al., 2007; Wernersson et al., 2005). Pigs have been recognized as
advantageous models for the study of numerous areas including: nutrition, toxicology,
dermatology, diabetes, cancer, eye diseases, cardiovascular diseases, degenerative joint
diseases, and skeletal growth (as reviewed by Matsunari et al., 2009). The emergence of
miRNA information was based on studies in non-mammalian species such as Drosophila,
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C. elegans, and Xenopus. Currently, humans have the most miRNAs identified (n= 1048),
followed by mice (n= 672), cattle (n= 662), and chimpanzees (n= 601). To date, the
presence of only 211 miRNAs has been reported in the domestic pig (Sus scrofa) by the
miRBase Registry (v. 16.0; September 2010), although more have been predicted (Curry
et al., 2009; Huang et al., 2008; Kim et al., 2006). The smaller number of porcine
miRNAs predicted using the computational approach is most likely due to the
unavailability of the complete pig genome database.
Figure 1.9. Phylogenetic trees showing evolutionary relationships among pigs, mice,
and humans.
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Figure 1.9. Due to a generally lower rate of nucleotide substitutions in the pig and human
lineages, the porcine sequences are more similar to the human than to the mouse
sequences. Overall, the miRNA sequences show the slowest evolution, followed by
exonic, 5' UTR, 3'UTR, intergenic and intronic regions, reflecting different levels of
selective constraint on these domains (Wernersson et al., 2005). The blue numbers
represent branch lengths determined via the HKY substitution model, a model of DNA
sequence evolution. Smaller numbers (and therefore shorter branches) indicate a lower
rate of nucleotide substitutions.
The first porcine miRNAs (n= 54) were identified by the analysis of 3.84 million
shotgun sequences from a total of 5 pig breeds as part of the Sino-Danish pig genome
project (Wernersson et al., 2005). These data led to the identification of the first porcine
miRNA cluster (miR-17-92) and to the first porcine miRNA expression analysis, using
PCR and northern blot (Sawera et al., 2005). They also demonstrated that the expression
of pre-miRNAs does not reflect the expression profile of mature miRNAs. Kim and
colleagues (2006) queried human and murine miRNAs against the pig genome to identify
58 potential miRNAs orthologs, six of which were experimentally verified via northern
blot analysis. Two years later, another group identified 19 new miRNAs in a cDNA
library generated from porcine fibroblast cells and demonstrated tissue-specific
expression (Kim et al., 2008). Using a novel concatameric cloning technique combined
with sequencing and PCR, Sharbati-Tehrani et al. (2008) identified 10 new miRNA in
various tissues from 31-day old piglets. Reddy et al. (2009) pooled and sequenced RNA
from pig heart, liver, and thymus to identify 120 conserved miRNA homologs. Twentytwo of the miRNAs were then examined in 14 different tissues by northern blot analysis.
Five miRNAs were ubiquitously expressed in all tissues, four miRNAs were highly
expressed in 13/ 14 tissues, and 10 showed distinct tissue-specific patterns.
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Various studies have also been conducted examining miRNA expression in porcine
muscle. Using a human, mouse, and rat microarray, Huang et al. (2008) predicted the
expression of 296 miRNAs in the skeletal muscle of fetal pigs (d33 and d65) and adults
and found that 255 of them had not yet been reported in pigs. One-hundred forty miRNAs
were differentially expressed > 2-fold between developmental stages (P< 0.001) and 51
changed > 10-fold. Five were chosen for PCR validation and four of those correlated
with the microarray data. McDaneld et al. (2009) measured global miRNA abundance by
examining transcriptome profiles of biceps femoris skeletal muscle from six sample
types, including cultured cells, during fetal development, and adult. Results provided
developmental profiles of seven miRNAs known to be involved in myogenesis, as well as
identified twelve potential novel miRNA in pigs. Maak et al. (2010) found no correlation
between the expression of ZDHHC9 (zinc finger, DHHC-type containing 9), a gene
encoding a protein involved in porcine congenital splay leg syndrome, and two miRNAs
predicted to target it; however, the authors neglected to examine protein expression.
With the development of deep sequencing technologies, three more papers have
recently been published that examined the porcine microRNAome. Nielsen et al. (2010)
identified the sequences and relative expression levels of 212 annotated miRNAs in
porcine longissimus dorsi. The expression levels, measured by sequence reads, varied
from single counts to several million reads. The most abundant miRNA was miR-1 which
had 30 million counts, corresponding to 87.1% of the total reads. A total of four miRNAs
(miR-1, -206, -133, and let-7) accounted for 94.5% of the total miRNA reads. Another
group (Sharbati et al., 2010) utilized deep sequencing followed by a custom microarray
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based on the sequences they had identified to decipher the porcine intestinal miRNA
transcriptome. They identified 332 miRNAs, of which 201 had not been described
previously in pigs.
Finally, Li et al. (2010) examined miRNA expression in ten small RNA libraries
corresponding to ten developmental stages: embryonic day 30, 45, 60, 75, 90, and 105,
birth, and post-natal day 30, 120, and 180. They detected 771 unique miRNA sequences
resulting from 862 miRNA precursors. Seventy-two of the 77 known porcine miRNAs
(based on miRBase v. 14.0) were identified. These previous three experiments compared
their deep sequencing results to miRBase release v. 14.0 (September 2009), which only
recognized 77 miRNAs. The next release of the miRBase will undoubtedly include
hundreds of novel porcine miRNAs based on the results of these publications.
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CHAPTER TWO
INTRODUCTION
In a decade‟s time, miRNAs have impacted nearly every field of biology and have
challenged established concepts pertaining to gene regulation. A PubMed search
(http://www.ncbi.nlm.nih.gov/pubmed/) shows a rapid growth in the number of papers
published concerning miRNA since their discovery (Figure 2.1). Since the
commencement of these studies, many advances have been made in the understanding of
miRNA function, regulation, expression, and target recognition and, accordingly, in the
methodologies in which miRNAs are studied. In 2006, the presence of only 54 miRNAs
had been reported in Sus scrofa by the miRBase Registry v. 8.0 (Griffiths-Jones, 2004;
Griffiths-Jones, 2006) . Today, 211 have been validated (Figure 2.2), whereas hundreds
more have been predicted.
Figure 2.1. Number of papers published concerning miRNAs per year
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Figure 2.1 shows the number of papers containing the word “microRNA” published in
each calendar year. The first year for which data are shown is 2001, which is the year
miRNAs were given their name. The data for 2010 represents papers published through
October 22, 2010.
Figure 2.2. Total number of miRNAs reported in human, porcine, and murine.
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Figure 2.2 shows the growth in miRNA identification in human, porcine, and murine as
reported by consecutive miRBase Registry releases.
Objective
There is a need to characterize the abnormal embryonic development associated with
ART and caused by aberrant miRNA expression. The objective of this dissertation
research was to determine the presence of miRNAs in porcine gametes and preimplantation embryos and to identify differences in miRNA expression between normal
and aberrant samples. We hypothesized that miRNAs are present in porcine reproductive
tissues and demonstrate high sequence similarity when compared to human miRNA
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sequences. Further, samples of compromised quality (abnormal sperm, in vitro produced
embryos), may exhibit aberrant miRNA expression when compared to normal samples.
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CHAPTER THREE
DETECTION OF PORCINE SPERM MICRORNAS USING A HETEROLOGOUS
MICRORNA MICROARRAY AND REVERSE TRANSCRIPTASE POLYMERASE
CHAIN REACTION

Introduction
miRNA exist in mammalian sperm (Amanai et al., 2006; Kotaja et al., 2006;
Ostermeier et al., 2005b; Yan et al., 2008), although no reports describe miRNA (or
RNA) in porcine sperm. Commercially available miRNA microarrays have been
developed (Ambion, Austin, TX; LC Sciences, Houston, TX; (Shingara et al., 2005)) and
microarray procedures have been reported for identification of specific miRNA
expression in various tissues (Barad et al., 2004; Bentwich et al., 2005; Ostermeier et al.,
2005a). Most microarrays are generated from human and rodent miRNA sequences and
no information is available for the efficacy of using a commercial array in cross-species
hybridizations. Many miRNAs exhibit high conservation among species indicating that
cross-species microarrays would be effective; however, failure to detect 100% of
miRNAs due to sequence mismatches at hybridization should be assumed. The
objectives of this study were to survey the miRNA present in boar sperm while
evaluating a heterologous miRNA microarray for the detection of miRNAs in porcine
tissue.
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Materials and methods
RNA isolation
For the microarray, total RNA was isolated from mature spermatozoa obtained from
commercial sources (Swine Genetics International, Eldora, Iowa) using TRIzol® Reagent
(Invitrogen, Carlsbad, CA) following the manufacturer‟s instructions. A plethora of
techniques, kits, and reagents were evaluated to determine those which provided
maximum RNA yield and acceptable quality. For subsequent RT-PCR assays, total RNA
enriched for small RNAs was isolated from sperm pellets using the mirVanaTM miRNA
Isolation Kit (Ambion Inc., Austin, TX) with some modifications. Upon removal from
storage, 1 mL of 0.5% SDS (Mallinckrodt Baker, Inc, Phillipsburg, NJ)/ 0.1% Triton-X
(Roche, Mannheim, Germany) was added to the sperm pellet and homogenized using a
26 g needle. Next, 6 mL lysis buffer was added and the mixture incubated at 65 ºC for 30
min. A 1:10 vol of miRNA homogenate additive was mixed with the sample and
incubated on ice for 20 min. A volume of acid-phenol: chloroform was added equal to
that of the lysis buffer, the solution vortexed for 45 sec, followed by a 10 min
centrifugation at 10,000 x g. The supernatant containing the total RNA was removed and
precipitated with 1.25 vol ethanol (99.5%). The solution was passed through a filter
cartridge using vacuum-mediated suction, washed, and RNA was extracted with 100 µl
elution solution, preheated to 95 °C. Sample concentration and quality were determined
by using the Nanodrop 1000 spectrophotometer (Thermo Fisher Scientific, Wilmington,
DE).
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Microarray
Microarray analysis was performed using a service provider (LC Sciences, LLC,
Houston, TX) to identify the miRNA profile present in porcine sperm cells. Five µg
sperm tcRNA pooled from multiple boars was size fractionated using a YM-100
Microcon centrifugal filter (Millipore, Bedford, MA) to isolate small RNAs. Small RNAs
less than 300 nt were 3‟- extended with a poly(A) tail using poly(A) polymerase. An
oligonucleotide tag was ligated to the poly(A) tail for later fluorescent dye staining.
Hybridization was performed overnight on a µParaflo microfluidic chip using a microcirculation pump (Atactic Technologies, Houston, TX). On the microfluidic chip, each
detection probe consisted of a chemically modified nucleotide coding segment
complementary to a known miRNA target (based on Sanger miRBase Release 9.0) or
control RNA and a spacer segment of polyethylene glycol to extend the coding segment
away from the substrate. MiRNA probes (n= 1260, in duplicate) were complementary to
known miRNAs from 19 different species, including 55 porcine probes. The detection
probes were made by in situ synthesis using photogenerated reagent chemistry. The
hybridization melting temperatures were balanced by chemical modifications of the
detection probes. Hybridization used 100 µL 6x SSPE buffer (0.90 M NaCl, 60 mM
Na2HPO4, 6 mM EDTA, pH 6.8) containing 25.0% formamide at 34 °C.
Tag detection was determined using fluorescence labeling with tag-specific dyes.
Images were collected using the GenePix® 4000B laser scanner (Molecular Device, Inc,
Sunnyvale, CA) and digitized using Array-Pro image analysis software (Media
Cybernetics, Silver Spring, MD). Data were analyzed by first subtracting the background
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and then normalizing the signals using a LOWESS filter (Locally-weighted Regression)
to compensate for the intensity difference between Cy3 and Cy5.
The signal intensities of quadruplicate reactions were averaged and, although the
microarray service provider recommended including all samples with detectable signal
greater than 30 relative fluorescent units (RFU) in analysis, a more conservative
threshold was adopted. Detectable transcripts included those with average signal intensity
greater than or equal to 100 RFU and were further divided into subcategories: low
expression (100- 999); moderate expression (1000- 9999), and; high expression (>
10,000).
PCR
RT-PCR was conducted using the mirVanaTM qRT-PCR miRNA Detection Kit
(Ambion, Austin, TX) and was used to verify the presence of 21 specific miRNAs: let-7a,
-7d, -7e, -7f, -7i, miR-9, -15b, -16, -21, -22, -24, -27a, -31, -92, -124a, -132, -150, -181a,
-182, -212, and -345. Human miRNA primer sets (mirVanaTM qRT-PCR Primer Set,
Ambion) were used to amplify an 85 to 90 bp product containing the 19 to 24 nt miRNA
sequence flanked by 28 nt from the PCR primer and 38 nt from the RT primer. The
reverse transcriptase reaction (10 µl) was incubated at 37 oC for 30 min then at 95 oC for
10 min. The PCR reaction (25 µl) was initiated with a cycle of 95 °C for 3 min followed
by 35 cycles of denaturation at 95 °C for 15 sec and primer annealing at 60 °C for 30 sec,
and then a final hold at 4 ºC. Ten µL of each reaction was subjected to non-denaturing
slab gel electrophoresis on a 50 mL 3.2% agarose gel containing ethidium bromide
(Fisher Scientific, Fair Lawn, NJ). Gels were electrophoresed in 5X Tris/ Borate/ EDTA

48

buffer at 85 V and product was visualized by exposure to ultraviolet light and
photography.
Sequence analysis
PCR products were ligated into the pDrive cloning vector and ligation reactions were
used to transform competent E. coli cells (Qiagen PCR Cloning Kit; Qiagen, Valencia,
CA). Clones containing the insert were propagated and the plasmids were isolated using
QIAprep Spin Miniprep Kit (Qiagen, Hilden, Germany). Plasmids were subjected to
dideoxynucleotide sequencing at the Clemson University Genomics Institute (Clemson,
SC) using M13 primers and sequences were compared to the corresponding human
sequence reported by the miRBase Registry Release 9.0 or 14.0, depending on when
results were received.
Results
Microarray
Microarray results showed that of the 1260 known miRNA probes used, 316 produced
a detectable signal (intensity ≥ 100 RFU). Nine hundred thirty nine had non-detectable
hybridization (74.8%), 162 had low detection (12.9%), 94 were moderately expressed
(7.5%), and 60 were highly expressed (4.8%) (Figure 3.1). A dye bias was identified on
five transcripts (0.4%) and these samples were deleted from analysis. Of the Sus scrofa
miRNA sequences listed in the miRBase Registry (n= 55), all were probed on the array,
and 23 were detected (41.8%). Sixteen probes complementary to the let family of
miRNAs produced a detectable signal. Significant hybridization signals were detected for
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293 target sequences that have not been previously reported previously in Sus scrofa. For
a list of detectable transcripts, see Appendix A.
Figure 3.1. Sperm miRNA per expression category

4.8%
7.5% (60)
(94)
12.9%
(162)

74.8%
(939)

non-detectable (0- 99)
low (100- 999)
moderate (1000- 9999)
high (>10,000)

Figure 3.1 shows the percentage of sperm miRNAs included on the microarray that were
non-detectable and that exhibited varying levels of expression according to relative
fluorescence units. The numbers in parenthesis represent the total number in each
expression category.
PCR
RT-PCR and gel analysis were used to confirm the presence of 21 specific miRNAs in
porcine sperm cells (Figure 3.2). The PCR results supported the microarray data with
four exceptions (Table 3.1): the miR-124a, -345, and -9 primers produced faint bands on
the gel, but were not detected in the array and, although miR-150 showed moderate
expression in the array, it was not detected by RT-PCR in RNA from three separate
sperm samples.
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Figure 3.2. MiRNA RT-PCR products
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Figure 3.2 is an image of a 3.2% agarose gel showing a selection of 85- 90 bp PCR
products stained with ethidium bromide and viewed under UV fluorescence. Lanes 1- 10
show specific miRNAs next to their corresponding negative controls and lane 11 shows
the 20 bp ladder (Sigma-Aldrich).
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Table 3.1. Sus scrofa sperm miRNAs identified by microarray, RT-PCR, and
sequencing
miRNA
ssc-let-7a1*
ssc-let-7d1,2
ssc-let-7e1, 2, 3*
ssc-let-7i4
ssc-let-7f
ssc-miR-124a3
ssc-miR-1321
ssc-miR-1501
ssc-miR-15b
ssc-miR-161*
ssc-miR-181a5
ssc-miR-1821
ssc-miR-21
ssc-miR-2121,2
ssc-miR-221*
ssc-miR-24
ssc-miR-27a
ssc-miR-311
ssc-miR-3451,5*
ssc-miR-9
ssc-miR-921*

Length
(nt)

Array
Expression

RTPCR

22
22
22
19
22
22
22
22
22
22
23
24
22
21
22
22
21
21
22
23
22

high
high
high
high
high
n.d.
low
mod
high
high
mod
low
high
low
low
mod
mod
n.d.
n.d.
n.d.
high

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

1

miRNAs not previously reported as being identified in pigs by the miRBase Registry.
An asterisk (*) indicates miRNAs that have been reported since the commencement of
these studies.
2
Sequence differs from reported human sequence.
3
Sequence differs from reported pig sequence.
4
Sequence differs from human sequence but is identical to reported pig sequence.
5
Sequence differs from reported pig sequence but is identical to human sequence.
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Sequencing
All miRNAs examined were successfully subcloned and sequenced. Those that were
not detected in sperm by RT-PCR were sequenced from porcine kidney RNA. The
majority of the sequences (85.7%) were identical to the human and/ or pig miRNA
sequences of the same identity listed in the miRBase Registry (Figure 3.3). Of those that
differed, it was only by one (n= 4) or two (n= 1) nucleotides. MiR-212 had a one
nucleotide change (A to C) at the tenth position from the 3‟ end compared to the human
sequence. Two miRNAs, let-7d and let-7e, had a U to C substitution at the 3‟ end when
compared to the human sequence. MiR-181a was identical to the human miR-181a, but
conflicts with reported pig sequence (the reported ssc-miR-181a has an extra uracil at the
3‟ position). The reported porcine miR-124a does not have a second uracil at the 5‟end,
although nine other species do (the human miR-124a was removed from the miRBase
Registry after these assays were conducted for unknown reason). The miR-345 sequence
was identical to the reported human sequence, but had two nucleotides different from the
reported pig sequence, which has a G to U substitution at the fifth position from the 3‟
end and a C deletion at the 3‟ end.
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Figure 3.3. Porcine miRNA multiple sequence alignment
let-7a
UGAGGUAGUAGGUUGUAUAGUU
UGAGGUAGUAGGUUGUAUAGUU
UGAGGUAGUAGGUUGUAUAGUU
**********************
let-7d
human
AGAGGUAGUAGGUUGCAUAGUU
porcine1 AGAGGUAGUAGGUUGCAUAGUC
*********************
let-7e
human
UGAGGUAGGAGGUUGUAUAGUU
porcine1 UGAGGUAGGAGGUUGUAUAGUC
porcine2 UGAGGUAGGAGGUUGUAUAGUU
*********************
let-7f
human
UGAGGUAGUAGAUUGUAUAGUU
porcine1 UGAGGUAGUAGAUUGUAUAGUU
porcine2 UGAGGUAGUAGAUUGUAUAGUU
**********************
let-7i
human
UGAGGUAGUAGUUUGUGCUGUU
porcine1 UGAGGUAGUAGUUUGUGCU--porcine2 UGAGGUAGUAGUUUGUGCU--*******************
miR-124a
porcine1 UUAAGGCACGCGGUGAAUGCCA
porcine2 -UAAGGCACGCGGUGAAUGCCA
*********************
miR-132
human
UAACAGUCUACAGCCAUGGUCG
porcine1 UAACAGUCUACAGCCAUGGUCG
**********************
miR-150
human
UCUCCCAACCCUUGUACCAGUG
porcine1 UCUCCCAACCCUUGUACCAGUG
**********************
miR-15b
human
UAGCAGCACAUCAUGGUUUACA
porcine1 UAGCAGCACAUCAUGGUUUACA
porcine2 UAGCAGCACAUCAUGGUUUACA
**********************
miR-16
human
UAGCAGCACGUAAAUAUUGGCG
porcine1 UAGCAGCACGUAAAUAUUGGCG
porcine2 UAGCAGCACGUAAAUAUUGGCG
**********************
miR-181a
human
AACAUUCAACGCUGUCGGUGAGUporcine1AACAUUCAACGCUGUCGGUGAGUporcine2AACAUUCAACGCUGUCGGUGAGUU
***********************
human
porcine1
porcine2

22
22
22
22
22
22
22
22
22
22
22
22
19
19
22
21
22
22
22
22
22
22
22
22
22
22
23
23
24

miR-182
human
UUUGGCAAUGGUAGAACUCACACU
porcine1UUUGGCAAUGGUAGAACUCACACU
************************
miR-21
human
UAGCUUAUCAGACUGAUGUUGA
porcine1 UAGCUUAUCAGACUGAUGUUGA
porcine2 UAGCUUAUCAGACUGAUGUUGA
**********************
miR-212
human
UAACAGUCUCCAGUCACGGCC
porcine1
UAACAGUCUCCCGUCACGGCC
*********** *********
miR-22
human
AAGCUGCCAGUUGAAGAACUGU
porcine1 AAGCUGCCAGUUGAAGAACUGU
porcine2 AAGCUGCCAGUUGAAGAACUGU
**********************
miR-24
human
UGGCUCAGUUCAGCAGGAACAG
porcine1 UGGCUCAGUUCAGCAGGAACAG
porcine2 UGGCUCAGUUCAGCAGGAACAG
**********************
miR-27a
human
UUCACAGUGGCUAAGUUCCGC
porcine1
UUCACAGUGGCUAAGUUCCGC
porcine2
UUCACAGUGGCUAAGUUCCGC
*********************
miR-31
human
AGGCAAGAUGCUGGCAUAGCU
porcine1
AGGCAAGAUGCUGGCAUAGCU
*********************
miR-345
human
GCUGACUCCUAGUCCAGGGCUC
porcine1 GCUGACUCCUAGUCCAGGGCUC
porcine2 GCUGACUCCUAGUCCAGUGCU***************** ***
miR-9
human
UCUUUGGUUAUCUAGCUGUAUGA
porcine1 UCUUUGGUUAUCUAGCUGUAUGA
porcine2 UCUUUGGUUAUCUAGCUGUAUGA
***********************
miR-92
human
UAUUGCACUUGUCCCGGCCUGU
porcine1 UAUUGCACUUGUCCCGGCCUGU
porcine2 UAUUGCACUUGUCCCGGCCUGU
**********************
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24
24
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22
22
21
21
22
22
22
22
22
22
21
21
21
21
21
22
22
21
23
23
23
22
22
22

Figure 3.3. Multiple sequence alignments were performed using ClustalW at default
settings to compare the pig sequence data generated in this experiment (porcine1) to the
corresponding reported human sequences (human) and to the reported porcine sequence
(porcine2). Asterisks indicate agreement among nucleotides at corresponding positions
among sequences.
Discussion
The RNA sample used in this study was isolated from collected ejaculates pooled
from multiple boars of the same breed, which is industry standard for swine production
facilities. Multiple boars were used to account for individual variation. The microarray
showed that 316 known miRNA probes hybridized to RNA sequences present in porcine
sperm RNA. The array results suggest the presence of 293 miRNAs that have not been
previously reported in Sus scrofa. Although porcine sequences hybridized to 316 of the
probes, it is possible that binding to multiple species of same miRNA caused the results
to appear inflated (e.g. miRNA, presumably all ssc-miR-16, bound to the hsu-miR-16, the
bta-miR-16, and the lca-miR-16 probes). Two hundred thirteen of the 316 detectable
signals were unique by assigned miRNA name, regardless of species.
Array results were confirmed via RT-PCR using 21 human miRNA primer sets, which
largely demonstrated the conservation of mature miRNAs between species. miRs-124a, 345 and -9 were present following the RT-PCR but not in the microarray. Because the
sensitivity of the PCR reaction allows for logarithmic amplification, it is possible that
they are present in porcine sperm cells in copy numbers too low to be detected by the
microarray hybridization. It should be mentioned that miR-124a was detected in one of
the two spots using Cy3 on the microarray and also that the human miR-124a was
removed from the miRBase Registry after assays were conducted (between the release of
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version 9.0 and 14.0) for unknown reasons. The sequence data conflicts with the
previously reported porcine miR-124a sequence (Reddy et al., 2009) in that the reported
ssc-miR-124a does not have an extra uracil on its 5‟ end.
Along with miR-124a, miR-181a also conflicts with previously reported porcine miR181a sequence in that the reported ssc-miR-181a does not have a uracil on its 3‟ end.
Both miR-124a and miR-181a were described previously by Reddy et al. (2009) as the
result of pyrosequencing. Possible explanations for these discrepancies include primer
artifact, the existence of possible paralogs of miR-182, or contamination of porcine
samples with human miRNA. Let-7i, while sharing 100% identity to the reported porcine
let-7i, differs from the human sequence due to a lack of three nucleotides at its 3‟ end
(GUU). A recent analysis of small RNA transcripts from porcine fetuses revealed that
both “isomiRs” are present in pig tissues, with the longer (22 nt) variant being much
more prevalent (Li et al., 2010). Although miRNAs tend to be conserved among species
over their entire length, no specific function has been allocated to the 3′ end of miRNAs,
as they do not appear to have a role in mRNA recognition or binding. The miR-345
sequence, although identical to the reported human miR-345 sequence, disagreed with the
reported pig sequence at two nucleotides.
Subsequent Real-time qRT-PCR analysis on miR-345 revealed an abnormal trendline
resembling a double sigmoid-curve (see Chapter IV), warranting its removal from
analysis. Although miR-150 did not produce a visible PCR product when analyzing
sperm RNA, the array showed moderate expression, and the product was visible when
RNA samples from other porcine tissues were examined. MiR-150 is present in pigs, as it
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was identified in other porcine tissue samples and sequenced in kidney (Appendix D). A
sequence very similar to miR-150 that is present in porcine sperm may have bound to the
miR-150 probe in the array. MiR-212 showed low expression in the array, but analysis
revealed that the sequence was not identical to the human or mouse sequences, differing
by one nucleotide. It is likely that the array hybridization signal would be higher if the
porcine sequence was probed rather than the heterologous sequences.
Results of this study verified that miRNAs are present in porcine sperm cells and that,
due to a high degree of sequence conservation among species, heterologous miRNA
microarrays and PCR primers are effective for porcine miRNA expression profiling in
sperm cells. Comparative data emphasized that, while a miRNA microarray provides a
suitable survey to ascertain which miRNAs are present in samples, it is obligatory to
verify microarray results by RT-PCR and sequencing.
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CHAPTER FOUR
DIFFERENTIAL EXPRESSION OF PORCINE SPERM MICRORNAS AND THEIR
ASSOCIATION WITH SPERM MORPHOLOGY AND MOTILITY

Introduction
The literature suggests that miRNAs are involved in spermatogenesis and that their
presence or absence in mature sperm could be indicative of aberrant development,
function and/or fertility (Amanai et al., 2006; Curry et al., 2009; Lian et al., 2009;
Maatouk et al., 2008; Yan et al., 2008). Mice lacking Dicer1, an enzyme required for
global miRNA synthesis, have morphologically abnormal elongating spermatids, exhibit
low motility, and are usually infertile (Maatouk et al., 2008). Lian et al. (2009) revealed
differential miRNA expression profiles of testes from patients with non-obstructive
azoospermia versus normal controls. Amanai et al. (2006), Yan et al. (2008), and, as
described in Chapter III, Curry et al. (2009) validated the presence of miRNAs (n= 54, n=
28, and n= 17, respectively) in mouse or boar sperm using RT-PCR, although more were
predicted based upon miRNA microarrays (n= 191 (Amanai et al., 2006) and n= 293
(Curry et al., 2009)).
Ostermeier et al. (Ostermeier et al., 2005b) proposed that RNAs could be useful for
male infertility prognosis and that specific male infertility factors may be identified using
genomic profiling of spermatozoa. Although sperm RNAs previously were thought to
play a negligible role in fertilization and early embryonic development, both paternal
mRNAs and miRNAs are delivered to the oocyte at fertilization (Amanai et al., 2006;
Ostermeier et al., 2004; Rassoulzadegan et al., 2006) and could affect the phenotype of
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the resulting offspring (Rassoulzadegan et al., 2006). If sperm messenger RNA can affect
the resulting offspring, it is conceivable that sperm miRNA may influence embryo
physiology as well. McCallie et al. (2010) detected aberrant embryo miRNA expression
from human blastocysts derived from patients with male factor infertility compared to
blastocysts produced from normal controls, suggestive of a contribution from sub-fertile
sperm affecting the phenotype of the resulting embryo.
Very little information as to the identity of miRNAs in porcine reproductive tissues
and their potential involvement in reproductive processes is known. Only a handful of
studies have characterized miRNAs in sperm (Amanai et al., 2006; Curry et al., 2009;
Yan et al., 2008) and no studies have investigated aberrant miRNA expression in mature
sperm. While male infertility may be caused by a variety of factors, the identification of
specific miRNAs that are associated with sperm structure and/or motility or that are
responsible for sperm fertility could lead to the development of a microarray-based
diagnostic assay to provide an assessment of male fertility. The objective of this study
was to identify differences in miRNA expression between normal porcine sperm samples
and those exhibiting morphological abnormalities or low motility.
Materials and Methods
Samples and semen preparation
Boar semen samples of normal motility and morphology from individual boars
(average motility= 92.8%, SD= 5.2; < 15% abnormal morphology) were used as controls
(n= 7). Samples of abnormal morphology (AB; n= 7) contained > 15% primary and/or
secondary abnormalities, while low motility samples (LM; n= 8) exhibited < 68% motile
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sperm (average motility= 47.5%, SD= 15.2). All samples were from single ejaculates
collected from commercial Duroc boars and were characterized at the boar stud at the
time of collection. Upon arrival, samples were centrifuged at 10,000 x g for 10 min. The
sperm pellets were washed twice in PBS, centrifuged, and the supernatant removed. The
pellets were snap-frozen in liquid nitrogen and stored at -80 °C until RNA isolation.
RNA isolation
Total cellular RNA enriched for small RNA was isolated from sperm pellets using the
mirVanaTM miRNA Isolation Kit (Ambion Inc., Austin, TX) with some modifications.
Upon removal from storage, 1 mL of 0.5% SDS (Mallinckrodt Baker, Inc, Phillipsburg,
NJ)/ 0.1% Triton-X (Roche, Mannheim, Germany) was added to sperm pellet and
homogenized using a 26 g needle. Next, 6 mL lysis buffer was added and the mixture
incubated at 65 ºC for 30 min. A 1:10 vol of miRNA homogenate additive was mixed
with the sample and incubated on ice for 20 min. A volume of acid-phenol: chloroform
was added equal to that of the lysis buffer, the solution vortexed for 45 sec, followed by a
10 min centrifugation at 10,000 x g. The supernatant containing the miRNA was removed
and precipitated with 1.25 vol ethanol (99.5%). The solution was passed through a filter
cartridge using vacuum-mediated suction, washed, and RNA was extracted with 100 µl
elution solution, preheated to 95 °C. Sample concentration and quality were determined
by using the Nanodrop 1000 spectrophotometer (Thermo Fisher Scientific, Wilmington,
DE).
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Quantitative real-time PCR
MiRNAs chosen for analysis were found to be differentially expressed by microarray
analysis (Appendices B and C), previously identified in boar sperm (Curry et al., 2009)
and/ or predicted to target genes that code for proteins involved in sperm structure,
motility, or metabolism (Table 4.1). Quantitative real-time PCR (qRT-PCR) was
conducted using the Realplex Mastercycler epgradient (Eppendorf, Hamburg, Germany).
Reactions were performed in quadruplicate on 10 ng sperm RNA using the mirVanaTM
qRT-PCR miRNA Detection Kit (Ambion, Austin, TX) and compared expression levels
of 11 specific miRNAs: let-7a, -7d, -7e, -7i, miRs-15b, -16, -182, -22, -24, -345, and -92.
Human miRNA primer sets (mirVanaTM qRT-PCR Primer Set, Ambion) were used to
amplify an 85 to 90 bp product containing the 19 to 24 miRNA sequence flanked by 28
bp from the PCR primer and 38 bp from the RT primer (Figure 3.2). The reverse
transcriptase reaction (10 µl) was incubated at 37 oC for 30 min, then at 95 oC for 10 min.
The PCR reaction (25 µl) was initiated with a cycle of 95 °C for 3 min followed by 35
cycles of denaturation at 95 °C for 15 sec and primer annealing at 60 °C for 30 sec, and
then a final hold at 4 ºC. Ct is defined as the point at which fluorescence rises
appreciably above the background (threshold) fluorescence and Cts were measured at a
constant threshold among plates.
As previously described, sperm miRNA expression levels were normalized to
endogenous miR-16 (Amanai et al., 2006; Liang et al., 2007; Ro et al., 2007a). MiR-16
exhibited stable expression among all sperm samples (Pearson correlation coefficient (r)=
0.954) and was validated using BestKeeper© version 1 software (Pfaffl et al., 2004). A
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more traditional housekeeping gene, 5S ribosomal RNA, was also evaluated, but
expression levels were irregular among samples (see also Peltier et al., 2008) and
BestKeeper© analysis showed it to be a poor normalizer (r = 0.597). Standard curves for
each miRNA were calculated on 5-fold serial dilutions of input reference RNA ranging
from 125 ng to 0.04 ng. Statistical analysis was performed using REST 2005 software
(Pfaffl et al., 2002) with significance at P < 0.05.
Functional inference of miRNA
The small number of porcine miRNAs and predicted mRNA targets relative to
other species is partly due to the incomplete pig genome database. Because miRNAs are
highly conserved among species, especially within mammals, it is extremely likely that
pigs share evolutionarily preserved miRNA binding sites with humans. In order to
elucidate the functions of differentially expressed miRNAs among control, AB, and LM
sperm populations, their target genes were extracted using MAMI server and database
(meta mir: target inference; http://mami.med.harvard.edu/) which provides a composite
prediction of target genes from five independent target prediction tools: TargetScan
(Lewis et al., 2005), miRanda (John et al., 2004), DIANA-microT (Maragkakis et al.,
2009), miRtarget (Grun et al., 2005) and picTar (Krek et al., 2005). Targets were
predicted for up- and down-regulated miRNAs from either AB or LM compared to the
controls. A MAMI sensitivity of 0.46 and a specificity of 1.0 were used to minimize Type
I Errors.
The Database for Annotation, Visualization and Integrated Discovery (DAVID v. 6.7;
http://david.abcc.ncifcrf.gov; (Dennis et al., 2003; Huang da et al., 2009)) is a free online
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bioinformatics resource that provides interpretation of biological themes associated with
large gene lists. DAVID was used to annotate MAMI-predicted target genes of
differentially expressed miRNAs and to identify significant functional enrichment in the
miRNA gene targets relative to the whole genome background. Entrez gene IDs were
uploaded to the functional annotation tool and enriched biological themes were analyzed
using a modified Fisher's exact test (EASE score; P < 0.05), medium classification
stringency, minimum enrichment score of 1.3, and a minimum fold enrichment of 1.5.
Functional annotation charts and clustering were analyzed to determine enriched
molecular functions, biological processes, cellular components, biochemical pathways,
and other gene annotations.

63

Table 4.1. MiRNAs and their predicted mRNA targets involved in sperm function

miRNA

Predicted Gene
Target

Official
Symbol,
Entrez
Gene ID

let-7a,
let-7d,
let-7e,
let-7i

High mobility
group AT-hook 2

HMGA2,
8091

let-7i

Carbonic
anhydrase II

CA2,
760

miR-15b
miR15b,
miR-182

Isocitrate
dehydrogenase 3
(NAD+) alpha
Rho GDPdissociation
inhibitor 1

Protein function

Reference(s)

Binds DNA in AT rich regions; predicted to affect
transcription by altering chromatin conformation;
important for spermatogenesis.

(Chieffi et al.,
2002)

Responsible for the maintenance of adequate
intraspermatozoal bicarbonate concentration; altered in
low-motility samples.
Involved in the TCA cycle; necessary for sperm energy
metabolism; expressed at lower levels in low-motility
patients.

(Tajima et al.,
1987; C. Zhao et
al., 2007)

ARHGDIA,
396

Associated with sperm structure; expression was decreased
in low-motility patients.

(Huang et al.,
2008)
(Vijayaraghavan
et al., 2000)

IDH3A,
3419

miR182,
miR-24

Glycogen synthase
kinase 3 alpha

GSK3A,
2931

Found in the flagellum and in the anterior portion of the
sperm head. The phosphorylation of GSK3A may initiate
motility in the epididymus and the expression was high in
motile compared to immotile sperm.

miR-22

Outer dense fiber
protein 1

ODF1,
4956

Necessary for sperm structure; aberrant expression causes
tail abnormalities in humans; used as a marker for
diagnosis of male factor infertility.

miR-24

Fascin homolog 1,
actin-bundling
protein

FSCN1,
6624

Actin-bundling protein involved in cell motility; decreased
expression associated with morphologic abnormalities.
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(C. Zhao et al.,
2007)

(Haidl et al.,
1991; Mortimer,
1997; Petersen et
al., 1999)
(Adams, 2004;
Cheng et al.,
2007)

Table 4.1 shows sperm miRNAs of interest and information regarding their predicted
mRNA targets involved in sperm function. It is important to note that a single miRNA
usually targets many genes and a single gene may be targeted by multiple miRNAs.

Results
Quantitative real-time PCR
Expression profiles of ten probe sets (let-7a, -7d, -7e, -7i, miRs-15b, -16, -182, -22, 24, and -92) were obtained from each sample. MiR-345, although chosen for Real-time
analysis, showed a peculiar trend line resembling a double sigmoid-curve and was not
analyzed further (data not shown). There were differences in the expression of five
miRNAs in AB or LM groups when compared to controls, all of which are predicted to
target mRNA that encode proteins responsible for sperm function. qRT-PCR revealed
significant increases in the expression of four miRNAs, let-7a, -7d, -7e, and miR-22, in
the AB group when compared to controls (Figure 4.1). Let-7a had nearly a 22-fold
increase in expression, whereas let-7d and -7e were 5.6-fold and 3.5-fold higher than
controls, respectively. miR-15b displayed a significant decrease in expression in the AB
group, with a 2.5-fold decrease compared to controls. miR-92 was not significantly
different between AB and controls, but the P-value was 0.10, and so should be considered
a potential sperm miRNA of interest. Two miRNAs, let-7d and let-7e, were increased in
the LM group when compared to controls (P < 0.05), with 2.5 and 6.2-fold increases in
expression, respectively. Although the expression of miR-24 was not significantly
different between LM and controls, a possible trend of increased expression was
observed (P= 0.09).
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Figure 4.1. Relative expression of AB and LM sperm miRNAs compared to controls
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Figure 4.1 shows fold changes (efficiency^-ΔΔCt) in miRNA expression in AB and LM as
compared to controls. Error bars represent standard error (SEM). Stars indicate
significance (P < 0.05).
Functional inference of miRNA
The bioinformatic analyses not only provided potential gene targets for the miRNAs
of interest, but also allowed inferences to be deduced by grouping the genes into
functional categories. When the differentially expressed miRNAs between the C and AB
groups were subjected to MAMI analysis, MAMI predicted 105 miRNA-gene
interactions, 62 of which were unique gene targets. DAVID analysis showed no
significant enrichment of any gene ontology (GO) category meeting the requisite
significance or enrichment scores. MAMI determined 55 targets of miR-15b, the only
miRNA down-regulated in the AB group, all of which were unique genes. Interestingly,
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DAVID results showed enriched GO categories of reproduction, spermatogenesis, male
gamete generation, and cell differentiation. Since qRT-PCR analysis failed to reveal
miRNAs that were down-regulated in the LM group, only the miRNAs that were upregulated, let-7d and let-7e, were utilized in the MAMI analysis. MAMI yielded 54
miRNA-gene interactions, with 38 unique gene targets. DAVID analysis showed GO
terms enriched for apoptosis and regulation of cellular and biological processes, both of
which, plausibly, would affect cell motility.
Discussion
Let-7a, -7d, and -7e are all predicted to target HMGA2 and were up-regulated in the
AB samples, with let-7d and -7e also exhibiting over-expression in the LM group (P <
0.05). HMGA2 is presumed to serve an essential function in spermatogenesis, as HMGA2
null mice produce no mature spermatozoa (Chieffi et al., 2002). Over-expression of let-7a
by transfection of let-7a precursor has been shown to decrease HMGA2 protein
production, whereas decreasing let-7a via anti-miRNA oligonucleotides resulted in an
increase in HMGA2 expression (Lee et al., 2007). In addition, HMGA2 has been
validated as a target of both let-7d and let-7e (Shell et al., 2007). HMGA2 expression is
highest from spermatocyte to spermatid stage (Chieffi et al., 2002), a period during which
cell division has ceased yet morphological changes ensue. It is possible that high levels of
let-7 expression during the spermatogenic process alter the production of proteins
required for normal spermatogenesis, potentially affecting proteins associated with
morphology and motility. MiR-22 was also up-regulated in the AB group and is

67

predicted to target ODF1. ODF1 is a protein required for normal sperm structure and is
over-expressed in asthenozoospermic (low motility) patients (C. Zhao et al., 2007).
MiR-15b was the only miRNA found to exhibit a significant decrease in expression in
this study in either group compared to controls. MiR-15b is predicted to target the mRNA
encoding ARHGDIA and IDH3A, both of which exhibited lower expression in
asthenozoospermic patients (C. Zhao et al., 2007). IDH3A is an enzyme involved in the
TCA cycle and the authors hypothesized that low expression of IDH3A may disrupt
sperm motility by altering sperm energy metabolism. As sperm cells are terminally
differentiated, it is possible that miRNAs are actually up-regulating protein production.
Because miR-15b was differentially expressed in AB samples and is predicted to target
statistically overrepresented genes in GO categories involved in sperm production,
further investigation of its role in spermatogenesis and sperm function is warranted.
The phenotype of specific morphological abnormalities and low motility can be
generated by scores of factors or conditions, both genetic and environmental. It should be
acknowledged that the individual sperm samples examined in this study did not contain
identical sperm cells, but were diluted with normal sperm; so technically, the AB and LM
samples were contaminated with controls and vice versa. The probability of acquiring an
ejaculate of homogenous sperm cells is unlikely, so laser capture microdissection could
potentially be employed to isolate populations of sperm cells of a single phenotype. A
sample of uniform cells would perhaps uncover differences in miRNA expression
currently masked by high standard deviation due to incongruent cell types.
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McCallie et al. (2010) found differential miRNA expression from blastocysts
produced from healthy donor eggs and sperm from patients with non-specified malefactor infertility, which can be due to decreased sperm count, poor morphology and/ or
low motility. They found that both miR-24 and let-7a were significantly down-regulated
in the male-infertility factor blastocysts when compared to controls. Interestingly, our
results showed no difference in miR-24 expression and a significant increase in the
expression of let-7a in AB sperm.
The results of GO groupings were due, in part, to the established sensitivity
parameters. In the MAMI analyses, a high specificity was used to avoid false positives,
resulting in a smaller pool of miRNA-mRNA interactions. An increase in predicted
targets (higher sensitivity) would affect DAVID enrichment scores, but would likely
sacrifice accuracy. Because miRNA target predictions are essentially educated
speculation, messenger RNA targets and the translation of the encoded protein should be
experimentally tested to validate miRNA function. Although the precise role of miRNA
in sperm remains to be elucidated, it is feasible that they are remnants of spermatogenic
processes, accumulated for a role in oocyte fertilization, delivered to the oocyte to
influence events in early embryonic development, or a combination thereof.
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CHAPTER FIVE
IDENTIFICATION OF MICRORNAS IN PORCINE OOCYTES AND IN VIVOPRODUCED EMBRYOS

Introduction
In mammals, miRNAs have been identified in the oocytes of mice (Tang et al., 2007)
and cows (Tesfaye et al., 2009; Tripurani et al., 2010) and in the embryos of mice (Cui et
al., 2009), cows (Castro et al., 2010; Coutinho et al., 2007), and humans (McCallie et al.,
2010; Tzur et al., 2009). No research has been reported regarding the presence or
function of miRNA in swine pre-implantation embryonic development. As demonstrated
in other mammalian species, I predict that miRNAs are present in porcine oocytes and
pre-implantation embryos. The objective of this study was to confirm that miRNAs are
present in porcine oocytes and embryos at the 8-cell and blastocyst stages and to
characterize trends in the expression levels of specific miRNAs at different stages of
early embryonic development.
Materials and Methods
Oocyte maturation
Cumulus oopherus complexes (COCs) aspirated from abattoir gilt ovaries were
obtained from Applied Reproductive Technologies, LLC (Madison, WI) and subjected to
a two-step maturation process as described by Sherrer et al. (2004). Oocytes were
matured in a maturation medium (tissue culture medium 199 (TCM199); Gibco, Grand
Island, NY) supplemented with 0.1% polyvinylalcohol, 3.05 mM glucose, 0.91 mM
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sodium pyruvate, 75 µg/ mL of potassium penicillin, 50 µg/ mL of streptomycin sulfate,
0.5 µg/ mL of ovine LH, 0.5 µg/ mL of porcine FSH, and 10 ng/ mL of murine EGF for
20- 22 h. They were the transferred to hormone-free TCM199 and incubated at 37 °C in
5% CO2 under sterile mineral oil for 24 h. Upon removal from media, oocytes were
washed once in PBS and vortexed in hyaluronidase (0.1%) to remove cumulus cells. To
confirm maturation, a subset of oocytes was stained using Hoechst 33342 (SigmaAldrich, St. Louis, MO) to visualize the extruded second polar body. Those oocytes
subjected to staining were discarded and the rest were combined into three pools, snapfrozen in liquid nitrogen, and stored at -80 °C.
Embryo collection
Cycling gilts (Landrace x Yorkshire) were subjected to estrous synchronization via
two injections of dinoprost tromethamine (10 mg, i.m.; LutalyseTM, Pfizer Animal Health,
New York, NY) twelve hours apart, with evaluation of estrus occurring twice daily (see
Appendix E). Artificial insemination was performed at standing estrus and 12 h poststanding estrus using commercially available Duroc boar semen (Swine Genetics
International, Cambridge, IA). Reproductive tracts were harvested at 4 or 7 days postinsemination and each uterine horn was flushed twice using 60 mL PBS containing
bovine serum albumin (4%; Sigma, St. Louis, MO), which was passed through a 75
micron filter to recover embryos. Embryos were staged, washed twice in PBS, and
transferred to 1.5 mL centrifuge tubes containing ~20 µL RNAlater® (Ambion, Austin,
TX). Samples were then snap-frozen in liquid nitrogen and stored at -80 °C until RNA
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isolation. All animal research was approved by the Clemson University Institutional
Animal Care and Use Committee (IACUC protocol #ARC2007-41).
RNA isolation
Total RNA enriched for small RNAs was isolated from embryos using the mirVanaTM
miRNA Isolation Kit (Ambion Inc., Austin, TX) from three pools of matured oocytes (n=
200, 50, and 5), three pools of in vivo produced 8-cell embryos (Day 4; n= 4, 3, and 4),
and three pools of in vivo produced blastocysts (Day 7- 7.5; n= 5, 4, and 5). Upon
removal from storage, 600 µL Lysis buffer was added to each sample and vortexed for 30
sec. A 1:10 vol of miRNA homogenate additive was mixed with each sample and
incubated on ice for 10 min. Six hundred µL acid-phenol: chloroform was then added and
the solution vortexed for 45 sec, followed by a 10 min centrifugation at 10,000 x g. The
supernatant containing the RNA was removed and precipitated with 1.25 vol ethanol
(99.5%). The solution was passed through a filter cartridge, washed, and RNA was
extracted with 100 µl elution buffer, preheated to 95 °C. Sample concentration and
quality were determined by spectrophotometry using the Nanodrop 1000
spectrophotometer (Thermo Fisher Scientific, Wilmington, DE).
PCR array
A total of 275 ng total cellular RNA from each pool of oocytes and embryos was
subjected to qRT-PCR probing for 88 mature human miRNAs (Table 5.1) that have been
correlated with development (Cell Differentiation & Development RT² miRNA PCR
Array; SABiosciences; Frederick, MD). Because many miRNAs are highly conserved
among species, the heterologous PCR array allowed for efficient cross-species

72

amplification. Specific miRNA abundance was classified according to the manufacturer‟s
recommendations and miRNAs that exhibited a Ct of > 35 were categorized as nondetectable, while detectable miRNAs were categorized as displaying low expression (Ct=
33- 34.9), moderate expression (Ct= 30- 32.9), or high expression (Ct= 25.5- 29.9)
(Figure 5.1).

lower expression
higher expression
Expression (Cts)

Figure 5.1. MiRNA expression categories

38.6
36.6

Non-detectable
(Ct > 35)

34.6
32.6

Low expression
(Ct = 33- 34.9)

30.6
28.6

Moderate expression
(Ct = 30- 32.9)

26.6
24.6

High expression
(Ct = 25.5- 29.9)

Figure 5.1 depicts
the categorization
of miRNA
expression as
determined by Ct.
Ct is defined as the
point at which
fluorescence rises
appreciably above
the background
(threshold)
fluorescence. Cts
were measured at a
constant threshold
among plates.

22.6

Data were analyzed using the RT2 Profiler PCR Array Data Analysis web-based tool
(SABiosciences; http://www.sabiosciences.com/pcrarraydataanalysis.php). Expression
levels were normalized using the Vandesompele method (Mestdagh et al., 2009) and Chisquare analysis was used to detect differences in proportions of the number of miRNAs
detected per expression category per group. P-values < 0.05 were deemed significant.

73

Functional inference of miRNAs
In order to elucidate the functions of differentially expressed miRNAs among oocytes,
8-cell embryos, and blastocysts, target genes were determined using MAMI server and
database (meta mir: target inference; http://mami.med.harvard.edu/). A MAMI sensitivity
of 0.46 and a specificity of 1.0 were used to minimize Type I Errors. DAVID v. 6.7
(http://david.abcc.ncifcrf.gov; (Dennis et al., 2003; Huang da et al., 2009)) was used to
annotate MAMI-predicted target genes of differentially expressed miRNAs and to
identify significant functional enrichment in the miRNA gene targets relative to the
whole genome background. Entrez gene IDs were uploaded to the functional annotation
tool and enriched biological themes were analyzed using a modified Fisher's exact test
(EASE score; P < 0.05), medium classification stringency, minimum enrichment score of
1.3, and a minimum fold enrichment of 1.5. Functional annotation charts and clustering
were analyzed to determine enriched molecular functions, biological processes, cellular
components, biochemical pathways, and other gene annotations.
Results
PCR array
A total of 86 miRNAs were detected in at least one of the stages examined (Table
5.1). Seventy-six miRNAs (86.4% of the 88 miRNAs probed) were detected in oocytes,
63 (71.6%) in 8-cell embryos, and 84 (95.5%) in blastocysts.
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Table 5.1. MiRNAs examined using the SABiosciences qRT-PCR miRNA array
miRNA

Accession

oocytes

8-cell

let-7a
let-7b
let-7c
let-7d
let-7e
let-7f
let-7g
let-7i
miR-1
miR-100
miR-101
miR-103
miR-106b
miR-10a
miR-10b
miR-122
miR-124
miR-125a-5p
miR-125b
miR-126
miR-127-5p
miR-128a
miR-129-5p
miR-130a
miR-132
miR-133b
miR-134
miR-137
miR-141
miR-142-3p
miR-142-5p
miR-146a
miR-146b-5p
miR-150
miR-155
miR-15a
miR-15b
miR-16
miR-17

MIMAT0000062
MIMAT0000063
MIMAT0000064
MIMAT0000065
MIMAT0000066
MIMAT0000067
MIMAT0000414
MIMAT0000415
MIMAT0000416
MIMAT0000098
MIMAT0000099
MIMAT0000101
MIMAT0000680
MIMAT0000253
MIMAT0000254
MIMAT0000421
MIMAT0000422
MIMAT0000443
MIMAT0000423
MIMAT0000445
MIMAT0004604
MIMAT0000424
MIMAT0000242
MIMAT0000425
MIMAT0000426
MIMAT0000770
MIMAT0000447
MIMAT0000429
MIMAT0000432
MIMAT0000434
MIMAT0000433
MIMAT0000449
MIMAT0002809
MIMAT0000451
MIMAT0000646
MIMAT0000068
MIMAT0000417
MIMAT0000069
MIMAT0000070

+
+
+
+
+
ND
+
+
ND
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
ND
+
ND
+
ND
ND
+
+
+
+
+
+
+
+

+
+
+
ND
+
ND
+
+
ND
+
+
+
+
+
+
ND
+
+
+
+
ND
+
+
ND
+
ND
+
ND
+
+
ND
+
ND
+
ND
ND
+
+
+

75

blastocysts
+
+
+
+
+
ND
ND
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
ND
+
+
+
+

Porcine Accession
MI0013085
n/a
MI0002445
n/a
MI0013086
MI0002446
MI0013087
MI0002447
MI0010682
MI0013128
MI0010678
MI0002448
n/a
MI0013101
MI0013102
MI0002413
MI0010680
MI0013115
MI0013172
n/a
MI0013144
MI0002451
MI0013169
MI0008217
n/a
MI0013089
n/a
n/a
n/a
MI0013134
n/a
n/a
MI0010685
n/a
n/a
MI0008211
MI0002419
MI0008213
MI0008214

miR-181a
miR-182
miR-183
miR-185
miR-18a
miR-18b
miR-192
miR-194
miR-195
miR-196a
miR-205
miR-206
miR-208
miR-20a
miR-20b
miR-21
miR-210
miR-214
miR-215
miR-218
miR-219-5p
miR-22
miR-222
miR-223
miR-23b
miR-24
miR-26a
miR-301a
miR-302a
miR-302c
miR-33a
miR-345
miR-370
miR-371-3p
miR-375
miR-378
miR-424
miR-452
miR-488
miR-498
miR-503
miR-518b

MIMAT0000256
MIMAT0000259
MIMAT0000261
MIMAT0000455
MIMAT0000072
MIMAT0001412
MIMAT0000222
MIMAT0000460
MIMAT0000461
MIMAT0000226
MIMAT0000266
MIMAT0000462
MIMAT0000241
MIMAT0000075
MIMAT0001413
MIMAT0000076
MIMAT0000267
MIMAT0000271
MIMAT0000272
MIMAT0000275
MIMAT0000276
MIMAT0000077
MIMAT0000279
MIMAT0000280
MIMAT0000418
MIMAT0000080
MIMAT0000082
MIMAT0000688
MIMAT0000684
MIMAT0000717
MIMAT0000091
MIMAT0000772
MIMAT0000722
MIMAT0000723
MIMAT0000728
MIMAT0000732
MIMAT0001341
MIMAT0001635
MIMAT0004763
MIMAT0002824
MIMAT0002874
MIMAT0002844

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
ND
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
ND
ND
ND
ND

+
+
+
+
+
ND
+
+
+
ND
+
ND
+
+
+
+
+
+
ND
+
+
ND
+
+
+
+
+
+
+
+
+
ND
+
+
+
+
+
ND
ND
ND
ND
ND
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+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
ND
+

MI0010686
n/a
MI0002439
MI0008218
MI0002455
n/a
MI0013127
n/a
MI0013141
MI0002457
MI0002440
MI0013084
n/a
MI0002423
n/a
MI0002459
MI0008220
MI0002441
MI0010687
n/a
n/a
MI0014770
MI0013151
n/a
MI0013112
MI0002428
MI0002429
MI0002432
n/a
n/a
n/a
MI0013117
n/a
n/a
n/a
MI0013088
MI0013135
n/a
n/a
n/a
MI0010684
n/a

miR-520g
MIMAT0002858
ND
ND
+
n/a
miR-7
MIMAT0000252
+
+
+
MI0002435
miR-9
MIMAT0000441
+
+
+
MI0002462
miR-92a
MIMAT0000092
+
+
+
MI0013125
miR-93
MIMAT0000093
+
+
+
n/a
miR-96
MIMAT0000095
+
+
+
n/a
miR-99a
MIMAT0000097
+
+
+
MI0013114
Table 5.1 shows the miRNAs probed for in the PCR array and their presence (+) or
absence (ND) in oocytes, 8-cell embryos, and blastocysts. If the miRNA had been
identified previously in pigs, the miRBase v. 14.0 accession number is also shown.
Let-7f and miR-503 were the only two miRNAs not detected in any of the samples.
Chi-square analysis showed differences in proportions of detectable vs. non-detectable
miRNAs between oocytes and 8-cell embryos (P= 0.026) and 8-cell embryos and
blastocysts (P< 0.0001), but not between oocytes and blastocysts (P= 0.064) (Figure 5.2).
Figure 5.2. Total number of detectable vs. non-detectable miRNAs at each stage
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Figure 5.2 shows the total number of detectable and non-detectable miRNAs at the
oocyte, 8-cell, and blastocyst stages. Chi-square analysis showed significant differences
in the proportions of detectable vs. non-detectable miRNAs between oocytes and 8-cell
embryos (P= 0.026) and 8-cell embryos and blastocysts (P< 0.0001).
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# of miRNAs

Figure 5.3. Number of detectable miRNAs at each stage by expression category
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Figure 5.3 shows the total number of detectable miRNAs at the oocyte, 8-cell, and
blastocyst stages broken down into expression categories of low, moderate, and high
expresssion. Chi-square analysis showed significant differences in the proportions of
miRNAs at various expression levels between oocytes and 8-cell embryos (P< 0.0001)
and 8-cell embryos and blastocysts (P< 0.0001).

In analyzing only the detectable miRNAs, Chi-square analysis showed significant
differences in the proportions of embryos at various expression levels between oocytes
and 8-cell embryos (P< 0.0001) and 8-cell embryos and blastocysts (P< 0.0001), but not
between oocytes and blastocysts (Figure 5.3).
The most highly expressed miRNAs in oocytes were miRs-21, -205, -195, -16, and 23b. The most highly expressed in 8-cell embryos were miR-125b, -205, -128, -17, and 125a-5p, and the most highly expressed miRNAs in blastocysts were miRs-210, -92a, 302a, -129-5p, and -205. Significant differences were found in the expression levels of 21
specific miRNAs among oocyte, 8-cell, and blastocysts stages (Table 5.2).
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Table 5.2. Expression levels of individual miRNAs among stages
Average Δ(Ct)
P-value
(Ct (miRNA) – Ct
(normalizer))
mature ID

oocytes

8-cell

blastocysts

oocytes
vs. 8-cell

oocytes vs. blastocysts
blastocysts vs. 8-cell

let-7b

-3.287

-1.223

0.400

0.033

0.015

0.265

let-7c

-1.220

0.017

1.107

0.094

0.043

0.002

let-7e

-1.670

0.263

2.053

0.159

0.114

0.005

let-7g

-1.950

0.167

3.043

0.114

0.078

0.001

miR-100

-1.017

-0.490

0.540

0.506

0.052

0.227

miR-101

-0.343

-0.290

1.880

0.982

0.038

0.089

miR-103

-1.637

-0.337

-2.240

0.360

0.812

0.003

miR-125b

-0.853

-3.503

0.143

0.158

0.405

0.042

miR-128

-2.130

-2.507

0.753

0.784

0.150

0.009

miR-142-3p

2.007

0.003

2.980

0.100

0.428

0.002

miR-182

-1.383

0.293

1.713

0.282

0.229

0.042

miR-183

1.783

-0.220

1.157

0.083

0.875

0.050

miR-18a

-1.587

-0.393

-1.093

0.012

0.018

0.152

miR-194

1.447

0.433

2.890

0.336

0.286

0.023

miR-222

1.267

0.147

-0.747

0.158

0.054

0.104

miR-223

1.323

0.120

0.580

0.824

0.850

0.015

miR-24

-3.020

-0.500

-0.957

0.042

0.051

0.425

miR-301a

1.053

0.183

0.860

0.177

0.935

0.042

miR-370

0.840

0.093

-0.973

0.441

0.043

0.656

miR-378

1.637

-0.077

-1.270

0.097

0.032

0.079

miR-99a

-2.130

-1.197

-0.420

0.286

0.181

0.029

Table 5.2 shows the delta Ct of miRNAs that exhibited significant differences in
expression (P< 0.05). A total of 21 miRNAs (of 88 examined) were differentially
expressed between oocytes and 8-cells, 8-cells and blastocysts, or oocytes and
blastocysts. Significant P-values are shown in red.
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Functional inference of miRNAs
The bioinformatic analyses not only provided potential gene targets for the miRNAs
of interest, but also allowed inferences to be deduced by grouping the genes into
functional categories. When the differentially expressed miRNAs between the oocytes
and the 8-cell embryos were subjected to MAMI analysis, 56 targets were identified, with
57 miRNA-gene interactions (one gene was a target of both let-7b and miR-24). The
MAMI results for the differentially expressed miRNAs between the 8-cell embryos and
blastocysts identified 188 gene targets with 253 miRNA-gene interactions. The
differentially expressed miRNAs between the oocytes and blastocysts yielded 123
possible miRNA-gene interactions, with 95 predicted gene targets.
DAVID analysis of genes predicted to be targeted by miRNAs differentially expressed
between oocytes and 8-cell embryos showed enriched gene ontology (GO) categories for
regulation of TGFβ receptor signaling, helicase activity, cellular protein localization, and
nucleotide binding. Targets of miRNAs differentially expressed between 8-cell embryos
and blastocysts were overrepresented in GO categories such as cell motion and migration,
helicase activity, chromatin organization, transcriptional activity, and a cellular
component enrichment of Golgi cis cistern. Lastly, targets of miRNAs differentially
expressed between oocytes and blastocysts had enriched GO categories for nucleotide
binding, positive regulation of transcription, epigenetic regulation of gene expression,
chromatin remodeling, and response to nitrogen and amines.
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Discussion
This study confirmed the presence of miRNAs in porcine oocytes and embryos at the
8-cell and blastocyst stages. A total of 86 miRNAs were detected in at least one of the
stages examined and differences in the proportions of detectable vs. non-detectable were
found between oocyte and 8-cell embryos and between 8-cell embryos and blastocysts,
with oocytes and blastocysts being the most similar. It is generally accepted that mature
oocytes of all species accumulate large amounts of RNA (Marello et al., 1992). The 8cell group had the lowest number of detectable miRNAs, which is consistent with the
shift from the maternal to embryonic genome and probably reflects the degradation of
maternal miRNAs. These data indicate that, like mRNA, miRNAs from maternal sources
may be depleted prior to the 8-cell embryonic stage [in porcine embryos] and that
miRNA expression post-8-cell embryonic stage is due to the activation of the fetal
genome.
The let-7 family, a highly conserved group of miRNAs shown to play critical roles in
developmental timing in non-mammalian species, was present in porcine oocytes and
embryos, and, for let-7b, -7c, 7e, and -7g, exhibited significantly higher expression in the
oocytes. Let-7 is involved in cell cycle regulation and has been referred to as the „master
regulator‟ of cell proliferation pathways (Johnson et al., 2005), having a role in activating
the terminal differentiation of organs, tissues, and specific cell types.
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CHAPTER SIX
COMPARATIVE MICRORNA EXPRESSION IN BOTH IN VIVO- AND IN VITROPRODUCED PRE-IMPLANTATION EMBRYOS
Introduction
Assisted reproductive technologies (ART) such as somatic cell nuclear transfer and
intracytoplasmic sperm injection frequently lead to abnormal embryonic growth;
however, the underlying mechanisms responsible for aberrant development remain
largely unknown. The assessment of embryo quality is prone to subjective biases and is
generally ill-defined (Ebner et al., 2003). Embryologists consider morphological
parameters such as cellular fragmentation, symmetry of blastomere cleavage, and rate of
development (Selk, 2009; Steer et al., 1992), but these characteristics can be poor
indicators of blastocyst and pregnancy rates (Graham et al., 2000). The measurement of
biochemical components in the embryo culture media as a non-invasive method to
deduce embryo quality have been studied, such as platelet activating factor (Roudebush
et al., 2002) and amino acid consumption (Booth et al., 2007; Brison et al., 2004), both of
which resulted in parameters correlated with pregnancy rates and live births.
Recent interest has turned to gene expression studies for a quantitative evaluation of
embryo quality and to identify embryos with the highest potential for developmental
competency. Van Montfoort et al. (2008) used microarray analysis to determine
differentially expressed genes between cumulus cells removed from oocytes that resulted
in early embryo cleavage following IVF versus cumulus cells removed from those that
did not cleave. They found the most differentially expressed were those involved in
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response to hypoxic conditions or delayed oocyte maturation. A similar study (Assou et
al., 2008) revealed that the expression levels of specific genes by cumulus cells were
significantly correlated with pregnancy outcomes. Although genes have been examined
in early embryonic development, data is scarce describing differences in gene expression
in in vivo- versus in vitro-produced embryos.
Small non-coding RNAs have been shown to regulate gene expression during
gametogenesis and embryonic development, and could play a role in the abnormal
development of embryos produced through ART. The ablation of the miRNA pathway is
embryonic lethal (Bernstein et al., 2003), indicating that the miRNA regulatory pathway
may contribute to the failure of miRNA-deficient embryos to develop or to establish and
maintain pregnancy. We predict that embryonic stress induced by in vitro culture systems
will lead to altered miRNA expression, when compared to in vivo-produced embryos at
corresponding stages. The miRNAs differentially expressed would be candidates for
markers of embryonic quality. The objective of this study was to identify differences in
miRNA expression between in vivo- and in vitro- produced porcine embryos at specific
stages of pre-implantation development.
Materials and Methods
In vivo- produced embryos
Estrous synchronization was achieved by feeding a synthetic progestin, Altrenogest
(MatrixTM; 15 mg p.o., Schering-Plough), to cycling gilts (Landrace x Yorkshire) for 14
consecutive days. Estrous detection was initiated 24 h after the discontinuation of Matrix
(Appendix E). Artificial insemination was performed at standing estrus and 12 h post
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standing estrus using commercially available boar semen (Swine Genetics International,
Cambridge, IA). Reproductive tracts were harvested at 2, 4, or 7 days post-insemination
and each oviduct or uterine horn was flushed twice using 5 mL or 60 mL PBS,
respectively, containing bovine serum albumin (4%; Sigma, St. Louis, MO), which was
then passed through a 75 micron filter to recover embryos. Embryos were examined,
assigned a developmental stage, washed twice in PBS, and transferred to individual 1.5
mL centrifuge tubes containing ~5 µL RNAlater® (Ambion, Austin, TX). Embryos
exhibiting a retarded developmental stage, a mid-mitotic phase, and/ or excessive
fragmentation were not analyzed. Samples were then snap-frozen in liquid nitrogen and
stored at -80 °C until RNA isolation. All animal research was approved by the Clemson
University Institutional Animal Care and Use Committee (IACUC protocol #ARC200741).
In vitro- produced embryos
The in vitro- fertilized (IVF) embryos in this study were obtained from Drs. Rebecca
Krisher and Melissa Paczkowski (University of Illinois, Urbana, IL). All chemicals were
purchased from Sigma Aldrich (St. Louis, MO, USA) unless specified otherwise. Ovaries
of cycling sows and prepubertal gilts were collected from two local abattoirs (Momence
Packing Co. and Indiana Packers Corp., respectively) and transferred to the laboratory in
30- 34 °C 0.9% (w/v) NaCl. Prepubertal ovaries were confirmed by the absence of
developed corpora lutea. Oocytes were vacuum aspirated from 3- 8 mm follicles using
an 18-gauge needle. Oocytes with several layers of unexpanded cumulus cells and
uniformly dark cytoplasm were selected and rinsed in Hepes-buffered synthetic oviductal
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fluid supplemented with 0.1% BSA (SOF-HEPES) (Gandhi et al., 2000; Tervit et al.,
1972). Selected oocytes were matured in vitro in TCM 199 medium (Invitrogen Corp.)
supplemented with 3.05 mM glucose, 0.91 mM pyruvate, 0.5 mM cysteine, 10 ng/mL
EGF, 0.01 units/mL LH and FSH (Sioux Biochemicals, Sioux City, IA), 1% v/v PSA
(100 IU/mL penicillin, 100 µg/mL streptomycin, 0.25 ng/mL amphotericin B; MP
Biomedicals) and 1 mL porcine follicular fluid, for 42 - 44 h in 7% CO2 in humidified air
at 38.7 °C. Following maturation, oocytes were denuded by vortexing for 3 minutes in
SOF-HEPES with 100 µg/mL (80-160 U/mL) hyaluronidase.
Denuded oocytes were washed three times in modified Tris-buffered medium
(mTBM) (Abeydeera et al., 1997a; Abeydeera et al., 1997b) supplemented with 2 mM
caffeine, 0.2% (w/v) fraction BSA and 1% v/v PSA. Oocytes were placed into 50 μL
drops of mTBM under 10 mL mineral oil (20 oocytes/ drop). Sperm preparation was
performed by placing 1 mL of chilled, extended (1: 5 dilution, Androhep EnduraGuard,
Minitube of America Inc., Verona, WI, USA) semen, warmed for 20 min, onto a gradient
of 45%: 90% PercollTM (GE Healthcare Life Sciences) and centrifuged for 20 min at 700
x g. The supernatant was removed and the remaining sperm pellet was washed in 5 mL
D-PBS (GIBCO Invitrogen) twice by centrifuging for 5 min at 1000 x g. Sperm were
then counted, diluted in mTBM, and added to drops (final volume 100 uL) containing
oocytes for a final sperm concentration of 250,000 sperm/mL. Gametes were coincubated for 5 h in 5% CO2 in humidified air. Following co-incubation, zygotes were
washed three times and cultured in 50 μL NCSU-23 (Petters et al., 1993) medium (10
zygotes/ drop) containing 0.4% crystallized BSA (MP Biomedicals) under 10 mL mineral
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oil in 5% CO2, 10% O2, 85% N2. Embryos were collected over seven replicates at the 4-,
8-, 16-cell and blastocyst stages, and subsequently frozen at -80 °C until RNA isolation.
RNA isolation
Total RNA enriched for small RNAs was isolated from individual embryos (n= 151)
using the mirVanaTM miRNA Isolation Kit (Ambion Inc., Austin, TX). Upon removal
from storage, 600 µL lysis buffer was added to the sample and vortexed for 30 sec. A
1:10 vol of miRNA homogenate additive was mixed with the sample and incubated on
ice for 10 min. A volume of acid-phenol: chloroform was added equal to that of the lysis
buffer and the solution was vortexed for 45 sec, followed by a 10 min centrifugation at
10,000 x g. The supernatant containing the RNA was removed and precipitated with 1.25
vol ethanol (99.5%). The solution was passed through a filter cartridge, washed, and
RNA was extracted with 100 µl elution buffer, preheated to 95 °C. Sample concentration
and quality were determined by spectrophotometry using the Nanodrop 1000
spectrophotometer (Thermo Fisher Scientific, Wilmington, DE).
Quantitative RT-PCR
Real time quantitative RT-PCR was conducted using the Realplex Mastercycler
epgradient (Eppendorf, Hamburg, Germany). Reactions were performed using the
Taqman® MicroRNA Reverse Transcription Kit and Taqman® MicroRNA Assays1
(Applied Biosystems, Foster City, CA) and examined the expression levels of four

1

During the course of the previous sperm studies, the Ambion miRNA qRT-PCR primer sets became
unavailable due to the purchase of Ambion by Applied Biosystems and the phasing out of those primers.
We chose to use the stem-loop RT-PCR-based TaqMan system (Figure 1.8) because of its specificity, the
availability of specific primers, and the growing number of reports describing its use.
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specific miRNAs: let-7b, miR-18a, miR-21, and miR-24. The miRNAs evaluated were
chosen based on the following criteria: 1) expression as described in Chapter V; 2)
bioinformatic analysis identifying messenger RNA targets of interest, and/ or; 3) their
validated presence in human pre-implantation embryos at corresponding stages.
A multiplex reverse transcription (RT) reaction was performed for each embryo RNA
sample by pooling the RT primers and concentrating them to 5X using a speed vacuum
(SVC100H-200, Savant, Thermo Fisher Scientific, Waltham, MA) as recommended by
Applied Biosystems technical support. Each RT reaction consisted of 10 ng embryo
RNA, 1 µL RT primer pool, 0.2 µL 100 mM dNTPs, 2 µL MultiScribeTM Reverse
Transcriptase (50 U/µL), 1 µL 10X reverse transcription buffer, 0.125 µL RNase
Inhibitor (20 U/µL), and was brought up to a total volume of 10 µl in nuclease-free H2O.
The RT reaction was incubated on ice for 5 min, at 16 oC for 30 min, 42 oC for 30 min,
and then at 85 oC for 5 min.
Due to the limited amount of embryo miRNA, a pre-amplification step was employed
to increase the starting amount of cDNA template. Each pre-amplification reaction
consisted of 6.25 µL 2X Taqman® PreAmp Master Mix, 4.38 µL of pooled Taqman
Assays containing each of the four miRNAs to be examined (0.2X each), and 1.89 µL
(1.89 ng cDNA) of RT reaction. The reactions were incubated at 95 oC for 10 min, 55 oC
for 2 min, 72 oC for 2 min, then 12 cycles of 95 oC for 15 sec and 60 oC for 4 min. Upon
completion, reactions were immediately placed on ice and diluted 4-fold by the addition
of 37.5 µL 0.1X TE. Samples were stored at -20 oC until PCR analysis.
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Each PCR reaction (20 µl) consisted of 1.33 µL of pre-amplification reaction, 10 µL
Taqman 2X Universal PCR Master Mix (No AmpErase® UNG), and 1 µL TaqMan
MicroRNA Assay (20X) and was initiated with a cycle of 95 °C for 10 min followed by
40 cycles of denaturation at 95 °C for 15 sec and primer annealing/ extending at 60 °C for
60 sec. Ct was defined as the point at which fluorescence rises appreciably above the
background (threshold) fluorescence and was measured at a constant threshold among
plates. To address potential pre-amplification bias and to validate the linear amplification
of cDNA during the pre-amplification process, standard curves were performed
comparing cDNA to pre-amplified cDNA. Results were consistent with those of other
studies (Chen et al., 2009; Mengual et al., 2008; Mestdagh et al., 2008) and showed an
unbiased linear amplification (Figure 6.1).
There was difficulty in determining a suitable normalization gene for this analysis.
RNU-48 endogenous control (Applied Biosystems) was evaluated, but was not present in
porcine tissues (although was found to be highly expressed in human control RNA tested
at equivalent RNA input). Ribosomal protein 18S had been previously reported to be
stably expressed in porcine pre-implantation development in vitro (Kuijk et al., 2007),
but we found the 18S Taqman primer set to demonstrate a high degree of non-specific
binding, as it amplified product not only from cDNA, but also from DNA, RNA, and in
the no template negative control. Although the undesired resulting bands were much
larger (~ 200 bp) than the anticipated 18S product size when viewed following gel
electrophoresis, they were indistinguishable from the desired product in real-time
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analysis. Let-7b was found to exhibit stable expression across all embryos and between
groups, nominating it as a suitable housekeeping gene.
Figure 6.1. Standard curves obtained from cDNA vs. pre-amplified cDNA
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Figure 6.1. Real-time
analysis
of miR-24
porcine kidney. Standard curves were
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automatic,
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OFF
performed to compare qRT-PCR reactions on cDNA (Panel A) to pre-amplified cDNA
(Panel B). Each resulted in identical slopes, but the Ct values for the pre-amplified cDNA
were decreased. These results are representative of all miRNA primer sets examined.
Statistical analysis
Expression levels of miRNAs were normalized to those of let-7b, which exhibited
minimal variation among all embryo samples. Normalization to let-7b was verified using
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both Normfinder (Andersen et al., 2004) and Bestkeeper (Pfaffl et al., 2004) software.
Standard curves for each miRNA primer set were calculated on 5-fold serial dilutions of
reference RNA ranging from 25 ng to 0.04 ng. Statistical analyses were performed using
JMP (version 8.0; SAS Institute, Inc., Cary, NC) at a 95% significance level and were
confirmed with REST-2009 software (Pfaffl et al., 2002). As recommended by Ambion
technical support, miRNAs that were non-detectable were assigned a Ct of 40 to allow
for appropriate statistical analyses.
Data were analyzed using a completely randomized two-way complete model. The
two factors of interest were group (i.e. production type), with levels IVO and IVF, and
stage, with levels 4-cell, 8-cell, 16-cell, and blastocyst. Raw Ct values were normalized to
let-7b and subjected to ANOVA testing. A test for interaction between the two factors
was performed before analyzing the main effects separately. The least squares means
were used to determine significant differences with PDIFF at alpha= 0.05.
Functional inference of miRNA
In order to elucidate the functions of differentially expressed miRNAs among embryos
from different developmental stages and between those produced via IVO and IVF, their
target genes were extracted using MAMI server and database (meta mir: target inference;
http://mami.med.harvard.edu/) which provides a composite prediction of target genes
from five independent target prediction tools: TargetScan (Lewis et al., 2005), miRanda
(John et al., 2004), DIANA-microT (Maragkakis et al., 2009), miRtarget (Grun et al.,
2005) and picTar (Krek et al., 2005). MAMI parameters were a sensitivity of 0.66 and a
specificity of 0.8.
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The Database for Annotation, Visualization and Integrated Discovery (DAVID v. 6.7;
http://david.abcc.ncifcrf.gov; (Dennis et al., 2003; Huang da et al., 2009)) was used to
annotate MAMI-predicted target genes of differentially expressed miRNAs and to
identify significant functional enrichment in the miRNA gene targets relative to the
whole genome background. Entrez gene IDs were uploaded to the functional annotation
tool and enriched biological themes were analyzed using a modified Fisher's exact test
(EASE score; P < 0.05), medium classification stringency, minimum enrichment score of
1.3, and a minimum fold enrichment of 1.5. Functional annotation charts and clustering
were analyzed to determine enriched molecular functions, biological processes, cellular
components, biochemical pathways, and other gene annotations.
Results
Embryos
A total of 151 embryos at 4-cell, 8-cell, 16-cell, or blastocyst stage were collected for
analysis. Seventy-seven were collected from gilts and 74 embryos were produced by in
vitro methods (Table 6.1).
Table 6.1. Total number of embryos examined by group and stage
4-cell

8-cell

16-cell

blastocyst

total

IVO

24

20

10

23

77

IVF

18

19

18

19

74

Total

42

39

28

42

151
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Quantitative RT-PCR
Table 6.2. Slopes and efficiencies of standard curves for each Taqman primer set
miRNA

slope

efficiency

let-7b

-3.667

1.87

miR-18a

-3.726

1.86

miR-21

-3.425

1.96

miR-24

-4.057

1.76

Let-7b
Let-7b was detected in all embryos evaluated. The average Ct for let-7b in the IVO
embryos was 26.93 (SEM= 0.13) and the average Ct of let-7b in the IVF embryos was
27.35 (SEM= 0.11). There were no differences in the detection of let-7b by group or
among stages (P> 0.05), advocating its use as a suitable reference gene.

Figure 6.2. Average Cts of let-7b by group and stage (non-normalized)
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Figure 6.2 shows mean Ct (± SEM) of let-7b in IVO and IVF embryos at different stages.
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miR-18a
MiR-18a was detected in 46 of the IVO embryos (59.7%) and in 43 of the IVF
embryos (58.1%). Although there were no differences between groups, Chi-square
analysis showed a significant difference in the proportions of embryos at different
developmental stages in which miR-18a was detectable vs. non-detectable (P < 0.05).
Differences were found in 4-cell vs. blastocyst (P < 0.001), 4-cell vs. 16-cell (P < 0.01),
and 8-cell vs. blastocysts (P < 0.001). Results also showed that, although there were no
effects of group or group*stage on miR-18a expression, there was an effect of
developmental stage (Figure 6.4).
Table 6.3. Detection of miR-18a in porcine embryos
Group
IVO
IVF
Total

Detection

4-cell

8-cell

16-cell

Blastocyst

Total

# present (%)

9 (37.5)

11 (55.0)

7 (70.0)

19 (82.6)

46 (59.7)

# undetectable (%)

15 (62.5)

9 (45.0)

3 (30.0)

4 (17.4)

31 (40.3)

# present (%)

5 (27.8)

9 (47.4)

12 (66.7)

17 (89.5)

43 (58.1)

# undetectable (%)

13 (72.2)

10 (52.6)

6 (33.3)

2 (10.5)

31 (41.9)

# present (%)

14 (33.3)

20 (51.3)

19 (67.9)

36 (85.7)

89 (58.9)

# undetectable (%)

28 (66.7)

19 (48.7)

9 (32.1)

6 (14.3)

62 (41.1)

Table 6.3 lists the number of embryos by group and by stage in which miR-18a was
detected. Although there were no differences by production type, Chi-square analysis
showed differences in proportions of detectable vs. non-detectable between 4-cell and
blastocyst (P < 0.001), 4-cell and 16-cell (P < 0.01), and 8-cell and blastocysts (P <
0.001).
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Figure 6.3. Detection rate of miR-18a in porcine embryos
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Figure 6.3 depicts the percentage of embryos by group and by stage in which miR-18a
was detected. The proportion of embryos in which miR-18a was detectable increased
with progressive developmental stages.
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Figure 6.4. Normalized miR-18a expression at different stages
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Figure 6.4 shows the normalized differences in Ct for miR-18a for the combined IVO and
IVF groups at each stage. Error bars represent the SEM. Bars not sharing letters are
statistically different (P < 0.05).
miR-21
MiR-21 was detected in 53 of the IVO embryos (68.8%) and in 50 of the IVF embryos
(67.6%). Like miR-18a, there were no differences between groups, but Chi-square
analysis showed a significant difference in the proportions of embryos at different
developmental stages in which miR-21 was detectable vs. non-detectable (P < 0.05).
Differences were found in 4-cell vs. blastocyst (P < 0.05) and 8-cell vs. blastocysts (P <
0.05). Results also showed that, as for miR-18a, there were no effects of group or
group*stage on miR-21 expression; however, there was an effect of developmental stage
(Figure 6.6). Differences were found between 4-cell embryos and blastocysts and
between 8-cell embryos and blastocysts (P < 0.05).
Table 6.4. Detection of miR-21 in porcine embryos
Group

Detection
# present (%)

IVO

# undetectable (%)
# present (%)

IVF

# undetectable (%)
# present (%)

Total

16-cell

Blastocyst

Total

15 (62.5) 13 (65.0)

8 (80.0)

17 (73.9)

53 (68.8)

9 (37.5)

2 (20.0)

6 (26.1)

24 (31.2)

10 (55.6) 11 (57.9) 12 (66.7)

17 (89.5)

50 (67.6)

8 (44.4)

6 (33.3)

2 (10.5)

24 (32.4)

25 (59.5) 24 (61.5) 20 (71.4)

34 (81.0)

103 (68.2)

8 (19.0)

48 (31.8)

4-cell

8-cell

7 (35.0)
8 (42.1)

# undetectable (%) 17 (40.5) 15 (38.5)

8 (28.6)

Table 6.4 lists the number of embryos by group and by stage in which miR-21 was
detected. Chi-square analysis showed a significant difference in the proportions of
embryos at different developmental stages in which miR-21 was detectable vs. nondetectable: 4-cell vs. blastocyst (P < 0.05) and 8-cell vs. blastocysts (P < 0.05).
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Figure 6.5. Detection of miR-21 in porcine embryos
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Figure 6.5 depicts the percentage of embryos by group and by stage in which miR-21 was
detected.
Figure 6.6. Normalized miR-21 expression at different stages

Normalized differences in Ct
(ΔΔCt)

9.00
8.00

a

a,b

7.00

a,b,c

6.00
c

5.00
4.00

3.00
2.00
1.00
0.00
4-cell

8-cell

16-cell
Stage

96

blastocyst

Figure 6.6 shows the normalized differences in Ct for miR-21 for the combined IVO and
IVF groups at each stage. Error bars represent the SEM. Bars not sharing letters are
statistically different (P < 0.05).
miR-24
MiR-24 was detected in 73 of the IVO embryos (94.8%) and in 68 of the IVF embryos
(91.9%). Chi-square analysis showed a significant difference in the proportions of IVO
vs. IVF embryos at the 8-cell stage in which miR-24 was detectable vs. non-detectable (P
< 0.05). There were no differences among embryo stages. There were significant effects
of both stage (Figure 6.8) and group*stage on miR-24 expression (Figure 6.9).
Differences were found between 4-cell and 16-cell, 8-cell and 16-cell, and between 8-cell
and blastocyst (P < 0.05). In the group*stage analysis, miR-24 was found to exhibit a
decrease expression in IVF embryos compared to IVO embryos at the 8-cell, but an
increase at the blastocysts stage (P < 0.05).
Table 6.5. Detection of miR-24 in porcine embryos
Group
IVO

IVF

Total

Detection

4-cell

8-cell

16-cell

Blastocyst

Total

# present (%)

23 (95.8)

20 (100.0)

9 (90.0)

21 (91.3)

73 (94.8)

# undetectable (%)

1 (4.2)

0 (0.0)

2 (8.7)

4 (5.2)

# present (%)

16 (88.9)

15 (78.9)

19 (100.0)

68 (91.9)

# undetectable (%)

2 (11.1)

4 (21.1)

1 (10.0)
18
(100.0)
0 (0.0)

0 (0.0)

6 (8.1)

# present (%)

41 (97.6)

35 (89.7)

27 (96.4)

40 (95.2)

141 (93.4)

# undetectable (%)

1 (2.4)

4 (10.3)

1 (3.6)

2 (4.8)

10 (6.6)

Table 6.5 lists the number of embryos by group and by stage in which miR-24 was
detected. Unlike the previous two miRNAs examined, there were no differences among
embryo stages; however, there were significant differences in the proportions of IVO and
IVF embryos at the 8-cell and blastocyst stages in which miR-24 was detectable vs. nondetectable (P < 0.05).
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Figure 6.7. Detection of miR-24 in porcine embryos
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Figure 6.7 shows the percentage of embryos by group and by stage in which miR-24 was
detected.
Figure 6.8. Normalized miR-24 expression at different stages
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Figure 6.8 shows the normalized differences in Ct for miR-24 for the combined IVO and
IVF groups at each embryo stage. Error bars represent the SEM. Bars not sharing letters
are statistically different (P < 0.05).

Figure 6.9. Normalized miR-24 expression by group and stage
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Figure 6.9 shows the normalized differences in Ct for miR-24 by group and stage. Error
bars represent the SEM (P < 0.05).
Functional inference
The bioinformatic analyses provided potential gene targets for the miRNAs examined
and allowed inferences to be deduced by grouping the genes into functional categories.
The MAMI-predicted targets of miR-18a included 28 genes. When these genes were
subjected to DAVID analysis, enriched GO terms included regulation of transcription,
exonuclease, cell migration, and transmembrane receptor protein tyrosine kinase
signaling pathway. Targets of miR-21 predicted by MAMI were a list of 37 genes, with
DAVID enriched terms of negative regulation of cell differentiation and a cellular
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location of nucleoplasm. There were 84 gene targets predicted for miR-24. DAVID
showed enriched terms for negative regulation of inflammatory response, regulation of
potassium ion transport, and negative regulation of response to external stimulus.
Discussion
This study demonstrated temporal expression of miRNAs in porcine embryos at
different stages of pre-implantation development and also between IVO and IVF embryos
at corresponding stages. At least three other reports exist describing miRNAs in in vitroproduced embryos of bovine and human (Castro et al., 2010; McCallie et al., 2010;
Tesfaye et al., 2009), but none compared miRNA expression of IVF embryos to IVO
embryos. This is the first report of miRNA identification in porcine pre-implantation
embryos and also the first describing differential miRNA expression between IVO and
IVF embryos in any species.
Not all of the miRNAs assayed were detectable in every embryo sample, so Chi-square
analysis was employed to assess proportions of detectable and non-detectable miRNAs
by group and by stage. It is possible that miR-18a and -21 were present in all embryos,
but at low levels which were undetectable using this assay. Rather than selectively
exclude the embryos in which specific miRNAs were non-detectable, a Ct of 40 was
assigned, which was beyond the limits of the standard curve and represented a nondetectable level.
It is conceivable that only competent embryos produced detectable levels of miR-18a
and miR-21, so those which developed to the blastocyst stage were more likely to express
higher levels of those miRNAs, whereas embryos not expressing miR-18a and -21
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underwent growth arrest were discarded for being developmentally retarded. A potential
target of miR-18a is hypoxia-inducible factor 1 (HIF-1), a transcription factor involved in
a cascade that mediates the effects of hypoxia within the cell. In a study investigating the
effects of the copper metabolism gene MURR1 domain (Commd1) on early embryonic
lethality in mice, researchers found that HIF-1 protein, along with at least 16 target genes
of HIF-1, were significantly upregulated in Commd1-/- embryos (van de Sluis et al.,
2007). If miR-18a is under-expressed in developmentally incompetent embryos, it could
lead to HIF-1 over-expression, which would result in abnormal embryogenesis (as shown
by Gnarra et al., 1997; Iyer et al., 1998) leading to embryonic loss in the pig.
Although miR-18a and miR-21 were not different between groups, they showed
differential expression among developmental stages. The proportion of embryos in which
miR-18a was detectable significantly increased with progressive embryonic stages. The
data presented in Chapter V showed that miR-18a was more highly expressed in the
porcine oocyte than both the 8-cell embryo and blastocyst. It is possible that oocytes and
potentially 2-cell embryos would express miR-18a more highly than in the 4-cell
embryos, and that miR-18a expression is lowest at the 4-cell stage. Tang et al. (2007)
compared miRNA expression from murine oocytes and embryos from the zygote through
the 8-cell stage and found that the total amount of miRNA is down-regulated by 60%
between the zygote and 2-cell embryo and that some miRNAs were lost by 95%,
suggesting that maternal miRNAs are actively degraded during the first cell division.
MiR-21 showed the same trend as miR-18a, although not as pronounced. Both the 4cell and 8-cell embryos had significantly lower expression of miR-21 than blastocysts. As
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reported by McCallie et al. (2010), there was no difference in miR-21 expression between
normal blastocysts and those produced by sub-fertile patients; however, McCallie found
that miR-21 was invariantly expressed across all blastocysts examined, while the present
study showed that it was undetectable in 19.0% of blastocysts. MiR-21 is predicted to
target genes involved in cell differentiation, some of which may be temporally expressed
in the early embryo. Because it‟s impossible to know which embryos were destined to
develop to full term, it would be interesting to conduct a study in which individual
blastomeres from embryos are biopsied and assayed for miR-18a, miR-21, and other
miRNAs of interest. The embryos could then be transferred to recipients and their
developmental rate correlated to their miRNA signature to retrospectively determine
differences in expression between competent embryos and those that fail to develop.
The only miRNA that was differentially expressed between IVO and IVF embryos
was miR-24, which exhibited a significant decrease in IVF embryos at the 8-cell stage,
but then increased significantly at the blastocyst stage. MiR-24 is predicted to target
Appl2 (adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper), a
protein required for the regulation of cell proliferation in response to extracellular signals.
The knockdown of Appl2 in zebrafish has been shown to induce apoptosis and early
embryonic death (Schenck et al., 2008). Interestingly, miR-24 was also examined in the
McCallie study (2010) and was found to be significantly decreased in embryos produced
by patients with male-factor infertility or polycystic ovarian syndrome compared to
normal donors. Bioinformatic analysis revealed miR-24 targets genes that appear to be
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involved in inflammation and stress, which could easily be extended to embryo in vitro
culture conditions.
This study identified changes in the expression of specific miRNAs across
developmental stages and between IVO and IVF porcine embryos at the 8-cell stage and
blastocyst stage. The miRNA differentially expressed are potential candidates for
markers of embryonic quality. Because there are dozens of predicted gene targets for
miRs-18a, -21, and -24, future studies should focus on validating potential targets of
interest and identifying differential protein expression of the predicted gene.
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CHAPTER SEVEN
CONCLUSIONS

The goals of these experiments were to identify miRNAs in porcine gametes and preimplantation embryos and to investigate differences in expression in normal versus
abnormal samples. Normal samples included sperm cells of standard motility and
morphology and in vivo- produced oocytes and pre-implantation embryos. Abnormal
samples included sperm samples with high percentages of morphological abnormalities
or samples exhibiting a high percentage of non-motile sperm, and embryos produced via
in vitro methods.
Using a heterologous RT-PCR approach, these studies demonstrated the presence of a
total of 92 miRNAs in porcine spermatozoa, oocytes, and/ or embryos at the 4-cell, 8cell, 16-cell, and blastocyst stages, with hundreds more predicted by miRNA microarray.
Subsequent qRT-PCR analysis showed differential expression of five miRNAs, let-7a, 7d, -7e, miR-15b, and -22, between normal sperm and morphologically abnormal sperm
or sperm samples exhibiting low motility. Messenger RNA targets of the differentially
expressed miRNAs encode proteins important for spermatogenesis, sperm structure, and/
or sperm cell metabolism. Differential expression was also shown in embryos at various
stages in development, demonstrating a temporal expression pattern of specific miRNAs
in pre-implantation embryo growth. More interestingly, miR-24 was differentially
expressed between in vivo and in vitro- produced embryos at the 8-cell and blastocyst
stages, supporting the need to characterize aberrant miRNA expression associated with
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the abnormal embryonic development correlated with ART. All of the miRNAs examined
demonstrated high sequence identity to the corresponding human miRNA sequences,
indicative of high conservation among species.
The results of the messenger RNA target predictions were due, in part, to the
established sensitivity parameters. In the MAMI analyses, a higher specificity was used
to avoid false positives, resulting in a smaller pool of miRNA-mRNA interactions. An
increase in predicted targets (higher sensitivity) would affect DAVID enrichment scores,
but would likely sacrifice accuracy. Because miRNA target predictions are essentially
educated speculation, messenger RNA targets and the translation of the encoded protein
should be experimentally tested to validate miRNA function.
To our knowledge, these are the first experiments characterizing miRNA expression in
porcine sperm, oocytes, and pre-implantation embryos and the only experiments
describing differential expression of miRNAs in aberrant sperm samples. Future
directions include examining miRNA expression in pure populations of sperm samples
(sperm with very specific phenotypes) or sperm samples of similar phenotypes that
exhibit differences in fertilization rates. It would also be interesting to compare miRNA
expression of IVO embryos to those produced via intracytoplasmic sperm injection
(ICSI) and somatic cell nuclear transfer (SCNT; cloning). It is possible that miRNAs are
introduced or left behind during these procedures, which would potentially impact
mRNA levels required for normal embryonic development. The characterization of a
miRNA signature of normal, competent sperm samples and embryos could aid in
choosing which samples are best suited for insemination or embryo transfer.
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Appendix A
Detectable miRNA in boar sperm via microarray

miRNA name
hsa-miR-223
rno-miR-223
hsa-miR-923
mmu-miR-762
hsa-miR-638
hsa-miR-26b
bta-miR-26b
hsa-miR-26a
hsa-miR-16
hsa-miR-23a
bta-miR-21
bta-miR-16
hsa-let-7a
hsa-miR-23b
bta-miR-23a
hsa-let-7f
ppa-miR-23b
mdo-miR-23a
lca-miR-16
mmu-miR-705
ggo-miR-30b
hsa-miR-21
hsa-miR-92a
hsa-let-7d
hsa-miR-15b
hsa-miR-654-5p
hsa-miR-574-5p
mmu-miR-92a
hsa-miR-25
ssc-miR-15b
hsa-miR-30b
ssc-miR-15b
hsa-let-7c
mdo-let-7d
hsa-miR-936
hsa-miR-191
ptr-miR-25
mdo-miR-191

mean signal (RFU)
59702.06
56174.51
38318.00
37208.12
35653.99
34647.68
34365.97
33810.49
32178.77
31295.31
31178.17
30959.85
30116.74
29179.58
28720.92
28658.01
28279.35
28227.22
27868.73
27757.09
25927.70
25577.15
24773.04
23617.52
23550.23
22870.89
22866.19
22180.42
21967.71
21406.16
20854.23
20522.24
20376.62
20279.34
20080.02
18659.87
18459.14
18040.50

miRNA name
mean signal (RFU)
hsa-miR-30c
16839.65
mmu-miR-709
16361.51
hsa-let-7g
15520.99
bta-miR-30a-5p
14934.28
hsa-let-7i
14215.54
hsa-miR-92b
14096.81
mmu-miR-34b-3p 13860.72
bta-miR-30d
13743.76
mdo-let-7g
13719.13
hsa-let-7e
12916.10
hsa-let-7b
12727.33
mmu-miR-155
12716.79
hsa-miR-195
12608.05
hsa-miR-671-5p
12302.36
ssc-let-7i
12063.06
hsa-miR-30d
12007.79
hsa-miR-30a
11794.77
hsa-miR-663
11423.54
bta-let-7e
10911.07
hsa-miR-155
10742.41
mdo-let-7i
10652.58
hsa-miR-34b
10504.04
bta-miR-15a
10467.61
hsa-miR-149*
10429.79
ggo-miR-29a
10246.35
hsa-miR-425
10067.79
bta-miR-425-5p
9991.11
hsa-miR-15a
9243.57
mdo-miR-15a
9118.64
mmu-miR-720
9051.11
mmu-miR-714
9016.40
bta-miR-150
8754.38
hsa-miR-150
8505.74
bta-miR-29a
8427.13
hsa-miR-29a
8358.40
bta-miR-107
7500.63
hsa-miR-483-5p
6782.70
hsa-miR-103
6622.63
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miRNA name
mmu-miR-711
hsa-miR-107
mmu-miR-483
hsa-miR-361-5p
bta-miR-30e-5p
hsa-miR-221
bta-miR-221
hsa-miR-15b*
bta-miR-27a
hsa-miR-151-5p
hsa-miR-146a
hsa-miR-765
hsa-miR-675
hsa-miR-98
hsa-miR-17
rno-miR-352
bta-miR-106
ggo-miR-17-5p
hsa-miR-423-5p
mmu-miR-466h
hsa-miR-939
hsa-miR-34c-3p
hsa-miR-185
hsa-miR-20a
ggo-miR-27a
bta-miR-195
hsa-miR-106a
hsa-miR-93
hsa-miR-24
hsa-miR-27a
ggo-miR-93
mmu-miR-685
hsa-miR-128a
bta-miR-93
bta-miR-20b
hsa-miR-140-3p
hsa-miR-106b
hsa-miR-320
ggo-miR-106a
bta-miR-140
rno-miR-466b
mmu-miR-106a
ggo-miR-20

mean signal (RFU)
6455.77
6254.70
6003.50
5716.80
5705.37
5297.46
5266.02
5188.56
4818.98
4659.47
4368.38
4334.00
4319.34
4058.01
3864.96
3813.40
3707.80
3629.20
3594.14
3579.99
3572.26
3549.91
3503.05
3483.87
3449.97
3371.07
3340.86
3325.51
3296.01
3076.16
3047.23
3003.90
2943.75
2878.11
2874.71
2739.17
2737.88
2656.78
2632.71
2626.90
2539.01
2450.19
2447.42

miRNA name
mean signal (RFU)
hsa-miR-29c
2320.12
hsa-miR-30c-1*
2317.27
bta-miR-181a
2281.89
hsa-miR-200c
2259.48
rno-miR-200c
2215.75
hsa-miR-181a
2148.81
ggo-miR-200c
2145.52
hsa-miR-148a
2127.00
mmu-miR-466f-5p 2062.22
hsa-miR-564
1881.33
ppa-miR-128a
1853.29
hsa-miR-222
1647.56
hsa-miR-374b
1588.78
hsa-miR-132
1575.23
hsa-miR-342-3p
1548.07
hsa-miR-27b
1508.60
hsa-miR-203
1501.77
rno-miR-200b
1499.01
bta-miR-181b
1486.28
bta-miR-342
1467.97
hsa-miR-371-5p
1388.17
mmu-miR-34c*
1361.44
hsa-miR-30e
1356.19
mdo-miR-24
1334.12
ggo-miR-181b
1317.50
hsa-miR-200b
1313.13
bta-miR-200b
1312.48
hsa-miR-672
1300.23
hsa-miR-186
1276.59
hsa-miR-513-5p
1225.19
mdo-miR-181b
1200.33
mdo-miR-22
1171.85
hsa-miR-628-3p
1161.45
hsa-miR-940
1156.93
mmu-miR-770-3p 1111.09
hsa-miR-20b
1040.63
hsa-miR-449b
1009.75
hsa-miR-10b
993.05
mmu-miR-582-5p 978.00
hsa-miR-188-5p
959.11
mmu-miR-721
911.89
hsa-miR-532-5p
900.73
mdo-miR-10b
890.08
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miRNA name
mean signal (RFU)
rno-miR-20b-5p
885.11
mmu-miR-763
868.50
hsa-miR-340
853.91
rno-miR-327
842.41
bta-miR-423
834.55
hsa-miR-182
822.35
bta-miR-142
792.47
mdo-miR-375
779.34
mdo-miR-203
775.90
hsa-miR-28-5p
762.17
ppy-miR-182
749.46
hsa-miR-28-3p
747.63
hsa-miR-652
741.73
hsa-miR-933
701.89
hsa-miR-449a
691.66
hsa-miR-148b
691.36
hsa-miR-768-5p
681.62
hsa-miR-744
678.20
ggo-miR-186
664.34
hsa-miR-363
641.79
hsa-miR-22
607.64
hsa-miR-375
577.13
mmu-miR-680
575.11
hsa-miR-122
540.33
hsa-miR-146b-5p 540.30
hsa-miR-660
539.44
hsa-miR-582-5p
534.38
hsa-miR-151-3p
517.49
hsa-miR-142-5p
517.18
mdo-miR-122
502.33
hsa-miR-150*
499.26
hsa-miR-19b
485.69
ssc-miR-122
480.30
hsa-miR-374a
449.57
hsa-miR-125b
421.16
hsa-miR-181b
418.35
bta-miR-363
395.62
hsa-miR-658
395.39
mdo-miR-29a
378.40
hsa-miR-335
375.16
mmu-miR-298
368.18
hsa-miR-659
367.79
hsa-miR-637
364.26

miRNA name
mean signal (RFU)
hsa-miR-425*
352.27
hsa-miR-362-5p
347.58
hsa-miR-801
344.15
hsa-miR-296-5p
340.47
rno-miR-10b
338.54
hsa-let-7b*
335.41
mmu-miR-468
331.38
hsa-let-7d*
327.38
ggo-miR-10b
322.96
mdo-miR-9*
305.59
hsa-miR-9*
303.57
hsa-miR-628-5p
303.09
hsa-miR-484
286.08
mmu-miR-182
285.18
hsa-miR-421
284.69
hsa-miR-494
281.76
mmu-miR-678
279.74
hsa-miR-500
267.88
hsa-miR-7-1*
266.52
ggo-miR-198
264.29
mmu-miR-466d-5p 259.13
rno-miR-345-3p
253.73
hsa-miR-193a-5p 253.47
bta-miR-99a
247.31
mmu-miR-702
243.13
hsa-miR-505*
236.14
mmu-miR-665
235.34
hsa-miR-324-3p
233.78
mmu-miR-290-5p 228.67
hsa-miR-99a
226.20
hsa-miR-134
225.95
bta-miR-7
209.82
hsa-miR-191*
209.31
hsa-miR-454
206.26
hsa-miR-149
205.34
hsa-miR-874
205.25
rno-miR-290
203.35
rno-miR-409-3p
193.10
mml-miR-198
190.02
hsa-miR-373*
189.75
mmu-miR-150*
189.37
mmu-miR-689
187.63
rno-miR-494
187.58
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miRNA name
mean signal (RFU)
hsa-miR-181d
187.54
hsa-miR-760
183.73
bta-miR-181c
182.35
mmu-miR-712*
178.29
mmu-miR-297a
176.51
mmu-miR-466f-3p 174.67
hsa-miR-612
173.12
rno-miR-324-3p
172.63
hsa-miR-130b
172.20
bta-miR-660
171.26
hsa-miR-650
169.04
hsa-miR-16-1*
163.05
hsa-miR-30e*
159.98
mmu-miR-425*
159.58
rno-miR-7a*
159.57
mmu-miR-327
159.33
hsa-let-7f-1*
157.55
mmu-miR-362-5p 157.37
hsa-miR-23a*
154.74
hsa-miR-331-3p
153.55
hsa-miR-10a
153.14
mmu-miR-207
152.54
hsa-miR-183
151.25
hsa-miR-532-3p
149.37
sla-miR-198
148.32
hsa-miR-30b*
146.86
bta-miR-139
143.27
hsa-miR-921
142.51
mdo-miR-100
141.59
hsa-miR-190b
141.05
hsa-miR-210
139.23
mmu-miR-700
135.93
hsa-miR-574-3p
133.24

miRNA name
mean signal (RFU)
rno-miR-505
131.77
hsa-miR-362-3p
131.13
hsa-miR-625
130.93
hsa-miR-563
130.68
mmu-miR-92a*
128.76
hsa-miR-100
127.79
hsa-miR-223*
127.33
mmu-miR-191*
126.14
rno-miR-345-5p
126.07
rno-miR-214
125.78
hsa-miR-625*
122.82
hsa-miR-602
121.60
hsa-miR-198
121.50
hsa-miR-212
120.55
mmu-miR-675-5p 120.25
bta-miR-200a
119.99
bta-miR-29b
119.71
hsa-miR-877
118.78
hsa-miR-324-5p
116.30
mmu-miR-715
115.99
mmu-miR-801
115.73
hsa-miR-636
115.10
hsa-miR-608
113.20
hsa-miR-365
112.94
mmu-miR-16*
111.98
hsa-miR-18a
111.97
ggo-miR-183
108.35
hsa-miR-885-3p
106.97
hsa-miR-129-5p
105.41
mmu-miR-292-5p 103.68
mmu-miR-483*
103.19
mmu-miR-345-5p 103.12
hsa-miR-500*
101.16
ppa-miR-188
100.00

110

Appendix B
Comparison of qRT-PCR results to microarray data

Introduction
The objective of this study was to compare results from qRT-PCR data comparing
miRNA expression among normal (control), morphologically abnormal (AB), and low
motility (LM) sperm miRNA, as reported in Chapter IV, to results obtained from a
miRNA microarray.
Materials and methods
Microarray
Five µg sperm total cellular RNA from individual sperm samples representing each
group, (C, AB, and LM) was hybridized to commercially available heterologous miRNA
microarrays (LC Sciences, LLC; Houston, TX). The RNA samples used were included in
the qRT-PCR analysis. The RNA was size fractionated using a YM-100 Microcon
centrifugal filter (Millipore, Bedford, MA) to isolate small RNAs. Small RNAs less than
300 nt were 3‟- extended with a poly(A) tail using poly(A) polymerase. An
oligonucleotide tag was ligated to the poly(A) tail for later fluorescent dye staining.
Hybridization was performed overnight on a µParaflo microfluidic chip using a microcirculation pump (Atactic Technologies, Houston, TX). Each detection probe on the
microfluidic chip consisted of a chemically modified nucleotide coding segment
complementary to a known miRNA target (based on Sanger miRBase Release 12.0) or
control RNA and a spacer segment of polyethylene glycol to extend the coding segment
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away from the substrate. MiRNA probes (n= 1097, in triplicate) were complementary to
known miRNAs from 8 different species, including 64 porcine probes. The detection
probes were made by in situ synthesis using photogenerated reagent chemistry. The
hybridization melting temperatures were balanced by chemical modifications of the
detection probes. Hybridization was carried out in 100 µL 6x SSPE buffer (0.90 M NaCl,
60 mM Na2HPO4, 6 mM EDTA, pH 6.8) containing 25.0% formamide at 34 °C.
Tag detection was determined using fluorescence labeling with tag-specific dyes.
Images were collected using the GenePix® 4000B laser scanner (Molecular Device, Inc,
Sunnyvale, CA) and digitized with Array-Pro image analysis software (Media
Cybernetics, Silver Spring, MD). Data were analyzed by first subtracting the background
and then normalizing the signals using a LOWESS filter (Locally-weighted Regression)
to compensate for the intensity difference between Cy3 and Cy5. The ratio of the two sets
of detected signals (log2 transformed, balanced) and P-values of the t-test were
calculated. Significantly different signal intensities were those with less than 0.01 Pvalues.
Functional inference of miRNA
The target genes of differentially expressed miRNAs (as determined by microarray
analysis) among control, AB, and LM sperm populations were extracted using the MAMI
server and database. Targets were predicted for up- and down-regulated miRNAs from
either AB or LM compared to the controls. A MAMI sensitivity of 0.46 and a specificity
of 1.0 were used to minimize Type I Errors. DAVID was used to annotate MAMIpredicted target genes of differentially expressed miRNAs and to identify significant
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functional enrichment in the miRNA targets relative to the whole genome background.
Entrez gene IDs were uploaded to the functional annotation tool and enriched biological
themes were analyzed using a modified Fisher's exact test (EASE score; P < 0.05),
medium classification stringency, minimum enrichment score of 1.3, and a minimum fold
enrichment of 1.5. Functional annotation charts and clustering were analyzed to
determine enriched molecular functions, biological processes, cellular components,
biochemical pathways, and other gene annotations.
Results
Microarray
Of the 1097 miRNAs probed, microarray results showed that 62 miRNAs were
differentially expressed between C and AB (5.7%), with 38 up-regulated in AB and 24
down-regulated. There were 66 miRNAs differentially expressed between C and LM
(6.0%), with 33 up-regulated and 33 down-regulated in LM. Forty-eight miRNAs were
differentially expressed in both the AB and LM samples, with 2 miRNAs (miRs-25 and 92a) up-regulated in AB but down-regulated in LM. Twenty-four miRNAs were upregulated in both AB and LM groups compared to controls and 19 were down-regulated
in both groups.
In contrast to the results described in Chapter III and other published reports (Ach et
al., 2008; Chen et al., 2009; Mattie et al., 2006), the qRT-PCR data reported in Chapter
IV did not support the microarray results. Unexpectedly, results were inversely related
(Table B.2).
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Table B.1. Number of miRNAs differentially expressed among normal (C),
abnormal (AB), and low motility (LM) sperm samples by array
C vs. AB

C vs. LM

Total

Differentially
expressed (%)

62 (5.7)

66 (6.0)

80 (7.3)

Up-regulated (%)

38 (3.5)

33 (3.0)

47 (4.3)

Down-regulated (%)

24 (2.2)

33 (3.0)

39 (3.6)

Table B.1 shows the number of miRNAs that were differentially expressed between
groups. The numbers in parenthesis are the percent of all miRNAs probed that were
differentially expressed. The Total column does not equal the sum of C vs. AB and C vs.
LM because some differentially expressed miRNAs were shared between groups.
Table B.2. Comparison of microarray and qRT-PCR results in AB and LM sperm
Abnormal
Low Motility
microarray
qRT-PCR
microarray
qRT-PCR
miRNA
let-7a

↓

↑

↓

nsd

let-7d

↓

↑

↓

nsd

let-7e

↓

↑

↓

↑

let-7i

↓

nsd

↓

↑

miR-15b

nsd

↓

↓

nsd

miR-182

↓

nsd

nsd

nsd

miR-22

nsd

↑

nsd

nsd

miR-24

nsd

nsd

nsd

nsd

miR-92

nsd

nsd

nsd

nsd

Table B.2 shows the microarray and real time qRT-PCR results in both AB and LM
groups compared to Controls. A down-pointing arrow (↓) indicates a significant
decrease (P < 0.05) in expression compared to Controls, whereas an upward-pointing
arrow (↑) indicates a significant increase in expression compared to Controls. Nsd= no
significant difference.
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Functional inference of miRNA
The bioinformatic analyses not only provided putative gene targets for the miRNAs of
interest, but also allowed inferences to be deduced by grouping the genes into functional
categories. When the differentially expressed miRNAs between the C and AB groups (as
determined by microarray) were subjected to MAMI analysis, targets were identified for
24 miRNAs (38.7%) with a total of 537 gene-miRNA interactions. Ninety of these genes
were predicted to be targeted by multiple miRNAs and resulted in 307 unique predicted
targets. The mean number of gene targets per miRNA was 26.6 with a minimum of 15
and a maximum of 49. The MAMI results for the differentially expressed miRNAs
between the C and LM identified targets for 27 (40.9%) miRNAs with a total of 557
gene-miRNA interactions. One hundred eighteen of the genes were predicted to be
targeted by two or more miRNAs, and again, coincidentally, resulted in 307 unique
predicted targets. The mean number of gene targets per miRNA was 21.4 with a
minimum of two and a maximum of 55. A combined analysis showed that a total of 33
miRNAs were predicted to target 392 unique genes.
DAVID analysis of genes predicted to be targeted by miRNAs differentially expressed
in AB sperm by microarray showed enriched gene ontology (GO) categories for
regulation of developmental processes, apoptosis, cellular development, cell projection
morphogenesis, nucleotide binding, GTP binding, and cellular component enrichment for
membrane-bound organelles. Targets of miRNAs differentially expressed in LM sperm
were overrepresented for GO categories such as regulation of metabolic, cellular, and
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biological processes, protein binding, protein kinase activity, metal/ ion binding, and
transcription factor activity, with a cellular component enrichment of the nucleus.
Discussion
Surprisingly, the PCR data showed a reverse trend when compared to the microarray
results. The same RNA samples used in the microarray were included in the PCR
analyses and also clashed with microarray data. These results conflicted with literature
reports that qRT-PCR results are supportive of microarray results. Although the cause for
this discord is unknown, it seems an unlikely coincidence that the results were nearly
opposite and are likely due to technician error, such as mislabeling of samples. Chen et
al. (2009) found low correlation between qRT-PCR (Taqman) and microarrays (LC
Sciences) when using different aliquots of the same RNA and noted that higher variation
was observed in miRNAs with low expression; however, in this study, the same aliquots
of RNA were used for microarray analysis and subsequently for qRT-PCR. Ach et al.
(2008) found high correlation of 88.3% of miRNAs compared using Taqman qRT-PCR
and Agilent microarrays. A study by Mattie et al. (2006) reported high correlation
between microarray and PCR data, with the exception of let-7, which was found to be upregulated in microarray data but not significantly different in Taqman qRT-PCR results.
It is possible that, in the microarray, multiple members of the let-7 family hybridized to
the same probes, thereby inflating the signal. These contradictory data reinforce the
recommendation to verify miRNA expression levels via PCR.
The miRNAs chosen for qRT-PCR analysis were chosen, in part, because of the
difference in expression determined by the microarray. Regardless of discrepancies
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between the microarray data and the qRT-PCR results, in general, the miRNAs that were
deemed significantly different via microarray were still significantly different by qRTPCR and those that showed no significant differences remained so across platforms.
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Appendix C
Differentially expressed miRNAs among control, AB, and LM sperm
Differentially Expressed miRNA between Control sperm and Morphologically
Abnormal or Low Motility Sperm as Determined by Microarray
hsa-miR-760
Upregulated in AB vs. Controls
hsa-miR-1182
hsa-miR-765
hsa-miR-1207-5p
ggo-miR-92
ptr-miR-1224-5p
rno-miR-92a
hsa-miR-1224-5p
hsa-miR-92b
hsa-miR-1228*
hsa-miR-939
hsa-miR-1268
Downregulated in AB vs. Controls
hsa-miR-1275
hsa-let-7a
hsa-miR-1300
hsa-let-7b
ptr-miR-1300b
ssc-let-7c
hsa-miR-1469
hsa-let-7d
hsa-miR-149*
hsa-let-7e
hsa-miR-150*
ssc-let-7f
hsa-miR-188-5p
hsa-let-7g
hsa-miR-1915
hsa-let-7i
ggo-miR-198
ssc-miR-103
ggo-miR-25
ssc-miR-125b
ptr-miR-25
hsa-miR-151-5p
ggo-miR-30a-5p
ssc-miR-16
hsa-miR-30c-1*
hsa-miR-182
ggo-miR-30d
ppy-miR-182
rno-miR-327
hsa-miR-1826
rno-miR-345-3p
hsa-miR-191
hsa-miR-371-5p
hsa-miR-20a
hsa-miR-375
ssc-miR-26a
hsa-miR-483-5p
ssc-miR-30b
hsa-miR-574-3p
ggo-miR-30b
hsa-miR-601
ssc-miR-30c
hsa-miR-638
hsa-miR-342-3p
hsa-miR-659
hsa-miR-720
hsa-miR-663
hsa-miR-923
hsa-miR-671-5p
hsa-miR-675
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Upregulated in LM vs. Controls
hsa-miR-1182
hsa-miR-1207-5p
hsa-miR-1224-5p
ptr-miR-1224-5p
hsa-miR-1228*
hsa-miR-1268
hsa-miR-1275
hsa-miR-1281
hsa-miR-134
hsa-miR-1469
hsa-miR-149*
hsa-miR-150*
hsa-miR-188-5p
ggo-miR-198
hsa-miR-198
ggo-miR-200c
hsa-miR-200c
rno-miR-200c
hsa-miR-30c-1*
hsa-miR-320a
rno-miR-327
rno-miR-345-3p
hsa-miR-371-5p
hsa-miR-483-5p
hsa-miR-574-3p
hsa-miR-663
hsa-miR-671-5p
hsa-miR-675
hsa-miR-760
hsa-miR-765
hsa-miR-874
hsa-miR-936
hsa-miR-939

Downregulated in LM vs. Controls
hsa-let-7a
hsa-let-7b
ssc-let-7c
hsa-let-7d
hsa-let-7e
ssc-let-7f
hsa-let-7g
hsa-let-7i
ssc-let-7i
hsa-miR-10b
ssc-miR-125b
hsa-miR-128
hsa-miR-1280
hsa-miR-1308
hsa-miR-151-5p
ssc-miR-15b
ssc-miR-16
hsa-miR-1826
hsa-miR-191
ggo-miR-25
ssc-miR-26a
ggo-miR-30b
ssc-miR-30b
ssc-miR-30c
ggo-miR-30d
rno-miR-329
hsa-miR-34b
hsa-miR-425
hsa-miR-720
ggo-miR-92
hsa-miR-923
rno-miR-92a
hsa-miR-92b
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Appendix D
Detection of miRNA in other porcine tissues

In addition to porcine gametes and embryos, endpoint RT-PCR was also performed on
RNA isolated from additional porcine tissues to examine tissue-specific expression.
Other tissues included: cumulus-oophorus complexes (COCs) aspirated from abattoir gilt
ovaries; lung, heart, kidney, liver, uterus, corpus luteum (CL), oviduct, and ovary
collected from gilts at time of slaughter; piglet testes collected at castration (7 days of
age), and; boar testes opportunistically harvested at euthanasia.
Total RNA enriched for small RNAs was isolated from tissue samples using the
mirVanaTM miRNA Isolation Kit (Ambion Inc., Austin, TX) as per manufacturer‟s
protocol. Sample concentration and quality were determined by spectrophotometry using
the Nanodrop 1000 spectrophotometer (Thermo Fisher Scientific, Wilmington, DE).
Endpoint RT-PCR was conducted using the mirVanaTM qRT-PCR miRNA Detection Kit
(Ambion, Austin, TX) and was used to determine the presence of 22 specific miRNAs:
let-7a, -7d, -7e, -7f, -7i, miR-9, -15b, -16, -21, -22, -24, -27a, -31, -92, -124a, -132, -134,
-150, -181a, -182, -212, and-345. PCR reactions, gel electrophoresis, and sequence
analysis were conducted as described in Chapter III.
Several miRNAs exhibited tissue-specific expression (Table D.1). It is interesting to
note that COCs and sperm showed the highest degree of variation in miRNA expression.
It is possible that the miRNAs absent in those tissues are expressed by endothelial cells of
blood vessels and, since COCs and sperm are the only two tissues examined that do not
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contain vasculature, were not present in those tissues. MiR-134 was not present in boar
testis or sperm cells, but was detected in every other tissue examined, including piglet
testis. MiR-124a expression appeared to be restricted to testis and sperm, indicating a
possible role in spermatogenesis.
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Table D.1. Identification of miRNAs in porcine tissues by RT-PCR
Tissue
corpus
lung heart kidney liver uterus
oviduct
luteum
miRNA
√
√
√
√
√
√
√†
hsa-let-7a
hsa-let-7d
√
√
√
√
√
√
√
√
√
√
√
√
√†
hsa-let-7e
√
√
√
√
√
√
√†
hsa-let-7f
hsa-let-7i
√
√
√
√
√
√
hsa-miR-124a
⁻
⁻
⁻
⁻
⁻
⁻
⁻
√
√
√
√
√
√
√†
hsa-miR-132
√
√
√
√
√
√
√
hsa-miR-134
√
√
√
√
√
√
√†
hsa-miR-150
√
√
√
√
√
√
√†
hsa-miR-15b
√
√
√
√
√
√
√†
hsa-miR-16
√
√
√
√
√
√
√†
hsa-miR-181a
√
√
√
√
√
√
√
hsa-miR-182
√
√
√
√
√
√
√†
hsa-miR-21
√
√
√
√
√
√
√†
hsa-miR-212
√
√
√
√
√
√
√†
hsa-miR-22
√
√
√
√
√
√
√†
hsa-miR-24
√
√
√
√
√
√
√†
hsa-miR-27a
√
√
√
√
√†
hsa-miR-31
⁻
⁻
√
√
√
√
√
√
√
hsa-miR-345
√
√
√
√
√
√
√†
hsa-miR-9
√
√
√
√
√
√
√†
hsa-miR-92
√= detected; √†= detected and sequenced; ⁻ = not detected.
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COC

ovary

sperm

√
√
√
√
√
⁻
√
√
√
√
√
⁻
⁻
√
√
√
√
√
√
√
⁻
√

√
√
√
√
√
⁻
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√

√†
√†
√†
√†
√†
√†
√†
⁻
⁻
√†
√†
√†
√†
√†
√†
√†
√†
√†
⁻
√†
√†
√†

boar
testis
√
√
√
√
√
√
√
⁻
√
√
√
√
√
√
√
√
√
√
√
√
√
√

piglet
testis
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√

Appendix E
Estrous grading scale for gilts

Background
Achievement of effective estrous detection in gilts can be difficult due to various
factors such as housing, heat stress, genetics (Rydhmer et al., 1994), and experience of
handlers. Cronin et al. (1982) found that 70% of gilts culled for not cycling had actually
ovulated, indicating either subtle estrous behaviors and/or poor estrous detection. In order
to facilitate estrous detection and eliminate subjective biases among multiple observers,
including previously untrained students participating in a Clemson University Creative
Inquiry project, an objective estrous scoring system was developed.
Methods
In order to optimize gilt estrous detection for artificial insemination and embryo
collection purposes, a numerical estrous scoring system was developed (Table E.1). A
maximum of twenty-two gilts were housed in individual pens (approx. 3 ft x 6 ft) in two
rows in the Isolation room at the Clemson University Swine Farm. Minimal contact
between gilts in adjacent pens was possible, as was visualization of gilts in pens on the
opposite aisle. Estrous checks were performed between 6am- 8am and again between
4pm and 6pm, every day. Students were instructed to observe each gilt and assign and
record estrous scores on gilts‟ individual records at each check. A boar, housed in the
same room, was permitted to walk in front of the gilts to elicit behaviors indicative of
estrus. Nose-to-nose contact was encouraged between the boar and every gilt.
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Table E.1. Estrous grading scale
Score

Behavioral and physical indicators of estrus

0

No signs

1

Interest in boar

2

Pink/ red vulva OR vulvar swelling

3

Pink/ red vulva, vulvar swelling/ mucous discharge, vocalization, ear-perking

4

Scores 1-3 and lordosis response; standing estrus

Heat score descriptions
At each heat check, all gilts were assigned a score from zero to four. A zero indicated
that the gilt exhibited no signs of estrus and usually referred to the gilt ignoring the boar.
Students were advised that every gilt must be encouraged to stand because a pig in strong
estrus may „lock up‟ while lying, so that a score of four could be easily be mistaken for a
zero. A score of one was appointed when gilts showed interest in the boar, either
standing up or walking to the front of the pen as he approached.
Swelling and/ or redness of the vulva can occur two to six days prior to estrus and it
was observed that some gilts exhibited redness prior to swelling while others showed
swelling first. If either of these were seen, a score of two of was assigned. Swelling and/
or redness sometimes dissipated immediately (~12 hr) prior to standing estrus. As
circulating estrogen levels rise due to the presence of dominant follicles, a vulvar mucous
discharge may occur. Another behavior associated with estrus is ear perking (also called
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ear pricking). Gilts hold their ears erect and pointed caudally, with intermittent twitching
in the forward direction. Little information as to the physiology behind or the adaptive
advantage of ear perking can be found in the literature, although it is likely a result of
elevated estrogen and may provide a visual cue to the boar.
A score of four was assigned only when a gilt was observed to be in standing estrus,
or „locking up‟. Locking up describes the posture of a female in estrus accepting the
application of pressure to her lower back, such that it mimics a boar attempting to mount
her. Her ears stand erect and the gilt braces her legs and sometimes pushes back against
the pressure. Sows in estrus may also mount other sows, but since the gilts in this study
were housed individually, such behavior was not observed; however, some gilts close to
estrus were observed attempting to climb the sides of their enclosure.
Results and Discussion
The scoring system provided effective communication among observers and allowed
students to track gilts throughout their cycles. Knowing the date of an animal‟s last estrus
was beneficial in predicting the next. Those that were not cycling (no signs of estrus for >
5 weeks or constant estrous behavior due to ovarian cysts) were culled from the study,
saving both labor and expense.
To the author‟s knowledge, this is the first porcine estrous scoring system developed.
A logical follow-up study would compare the pregnancy and litter sizes resulting from
either the described estrous scoring technique or traditional heat check methods. Another
interesting study would utilize ultrasonography to determine the time of ovulation
relative to estrous behaviors.
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